Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
HumanPhenoBroad nasal tip

ALX3 SATB2 KAT6A QRICH1 GATAD2B PHF21A BPTF SETBP1 LTBP1 CTNNB1 CPLANE1

1.24e-061595811HP:0000455
HumanPhenoThin upper lip vermilion

SATB2 KAT6A TNRC6B CILK1 QRICH1 GATAD2B BPTF KMT2D SETBP1 NPAP1 KCNMA1 DENND5A CTNNB1 KNL1

1.76e-053395814HP:0000219
HumanPhenoThin lips

SATB2 KAT6A TNRC6B CILK1 QRICH1 GATAD2B BPTF KMT2D SETBP1 NPAP1 KCNMA1 DENND5A CTNNB1 KNL1

1.76e-053395814HP:0000213
HumanPhenoKidney cancer

PHF21A AURKA USF3 DLC1 SETBP1 COL14A1 PAX6 CTNNB1

4.21e-05116588HP:0005933
HumanPhenoAbnormal nasal tip morphology

ALX3 SATB2 KAT6A CILK1 QRICH1 GATAD2B PHF21A BPTF KMT2D HECW2 SETBP1 LTBP1 CTNNB1 CPLANE1

7.53e-053865814HP:0000436
DomainPHD

KAT6A PHRF1 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D PHF13

1.77e-097517310PF00628
DomainZnf_PHD-finger

KAT6A PHRF1 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D PHF13

2.97e-097917310IPR019787
DomainPHD

KAT6A PHRF1 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D PHF13

9.69e-098917310SM00249
DomainZnf_PHD

KAT6A PHRF1 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D PHF13

1.21e-089117310IPR001965
DomainZF_PHD_2

KAT6A PHRF1 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D PHF13

1.84e-089517310PS50016
DomainZF_PHD_1

KAT6A PHRF1 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D PHF13

2.03e-089617310PS01359
DomainZnf_FYVE_PHD

KAT6A PHRF1 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D PHF13

1.14e-0614717310IPR011011
Domain-

EXPH5 KAT6A PHRF1 MIB2 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D MYLIP MARCHF11 PML PHF13

1.95e-05449173153.30.40.10
DomainZnf_RING/FYVE/PHD

EXPH5 KAT6A PHRF1 MIB2 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D MYLIP MARCHF11 PML PHF13

2.52e-0545917315IPR013083
DomainZinc_finger_PHD-type_CS

KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF

3.04e-05651736IPR019786
DomainULD

SATB2 SATB1

8.53e-0521732IPR032392
DomainCUTL

SATB2 SATB1

8.53e-0521732IPR032355
DomainULD

SATB2 SATB1

8.53e-0521732PF16534
DomainCUTL

SATB2 SATB1

8.53e-0521732PF16557
DomainNLGN4

NLGN4Y NLGN4X

8.53e-0521732IPR030025
DomainInterferon_reg_fac2-bd1_2_Znf

IRF2BP2 IRF2BP1

2.54e-0431732IPR022750
DomainIRF-2BP1_2

IRF2BP2 IRF2BP1

2.54e-0431732PF11261
DomainStriatin_N

STRN3 STRN4

2.54e-0431732IPR013258
DomainStriatin

STRN3 STRN4

2.54e-0431732PF08232
DomainCNH

TNIK MINK1 MAP4K5

2.64e-04141733SM00036
DomainCNH

TNIK MINK1 MAP4K5

3.27e-04151733PF00780
DomainCNH

TNIK MINK1 MAP4K5

3.27e-04151733PS50219
DomainCNH_dom

TNIK MINK1 MAP4K5

3.27e-04151733IPR001180
DomainSUZ

R3HDM2 R3HDM1

5.06e-0441732IPR024771
DomainAMOP

ISM2 MUC4

5.06e-0441732SM00723
DomainSUZ

R3HDM2 R3HDM1

5.06e-0441732PS51673
DomainAMOP

ISM2 MUC4

5.06e-0441732PF03782
DomainAMOP_dom

ISM2 MUC4

5.06e-0441732IPR005533
DomainAMOP

ISM2 MUC4

5.06e-0441732PS50856
DomainNlgn

NLGN4Y NLGN4X

8.38e-0451732IPR000460
PathwayWP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY

SATB2 DAZ4 DAZ1 MEF2D GATAD2B TRIM33 KMT2D SATB1 NFKB1 CTNNB1 PML KPNB1

7.48e-0630111712MM15983
PathwayWP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA

HLX GAL3ST4 C3 ELF4 TNFRSF1B

1.17e-04581175MM15966
PathwayREACTOME_NEUREXINS_AND_NEUROLIGINS

NLGN4Y NLGN4X LRRTM4 EPB41

1.35e-04321174MM15326
PathwayWP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA

HLX GAL3ST4 C3 ELF4 TNFRSF1B

1.37e-04601175M39508
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

CRADD NLGN4Y MINK1 KAT6A TOM1 TNRC6B CILK1 IQCN ARHGEF16 FOXJ3 ESCO1 SEPTIN6 HNRNPL BICD1 PLEKHG4B BPTF USF3 MRTFB SMG7 TULP4 TBC1D22A CLMN KIAA1217 SETBP1 KCNMA1 AFF1 SEMA6A TANC1 LTBR DENND5A CKAP2 PATJ NFAT5 CRAMP1 EPB41

7.19e-1414891823528611215
Pubmed

Human transcription factor protein interaction networks.

GTPBP4 IRF2BP2 SATB2 HIVEP1 IRF2BP1 RBM33 TNRC6B SLC5A9 R3HDM2 GPATCH8 MEF2D GATAD2B SEPTIN6 PHF21A HNRNPL MRPL39 TRIM33 BPTF PHC3 KMT2D SMG7 SATB1 CNOT9 TTC31 PRRC2C ATF7IP NFKB1 ELF4 PABPC1L PAX6 R3HDM1 MGA PML

6.72e-1314291823335140242
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

CRTC3 TSC22D2 KMT2E WNK1 FOXJ3 FAM186B PLEKHG4B PHC3 ZNF469 USF3 MRTFB FAM193A TULP4 MAP4K5 SETBP1 AFF1 PATJ MGA KPNB1

1.63e-124301821935044719
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

TANC2 THSD7A MARK1 ZNF618 EXPH5 COBLL1 CILK1 ZFC3H1 WNK1 ESCO1 TMEM200A GATAD2B SEPTIN6 CEP350 TRIM66 USF3 TULP4 SSH2 ZNF160 MGA

1.95e-124931822015368895
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

TANC2 CRTC3 HIVEP1 KIF26B EXPH5 COBLL1 MINK1 WNK1 ARHGEF16 MEF2D CEP350 DLC1 CLMN PRRC2C KIAA1217 FMN2 NHS TANC1 SSH2 CKAP2 R3HDM1 PATJ EPB41 PML

2.94e-118611822436931259
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

SATB2 HIVEP1 ZC3H13 ZKSCAN8 FOXJ3 MEF2D GATAD2B PHF21A PHF1 ZBTB37 ZC3H10 BPTF SATB1 NFIL3 NFKB1 PAX6 CTNNB1 ZNF160 MGA NFAT5 UTY PML PHF13

5.20e-118081822320412781
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

TNIK TANC2 STRN3 CRTC3 RBM33 POLD2 TOM1 WNK1 MEF2D SEPTIN6 CEP350 AURKA TRIM33 MRTFB SMG7 CNOT9 KIAA1217 NFKB1 PABPC1L SSH2 CTNNB1 AMOTL2 R3HDM1 DEPDC7

1.26e-0910381822426673895
Pubmed

Functional proteomics mapping of a human signaling pathway.

CNKSR1 HIVEP1 THSD7A IRF2BP1 EXPH5 TOM1 CILK1 QRICH1 GATAD2B KMT2D MRTFB ATF7IP CSPG4 AFF1 CTNNB1 MGA KNL1 KPNB1

2.58e-095911821815231748
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

IRF2BP2 IRF2BP1 TNRC6B MEF2D GATAD2B CEP350 TRIM33 KMT2D FAM193A SMG7 MGA

4.10e-091841821132908313
Pubmed

A human MAP kinase interactome.

CRTC3 HIVEP1 RBM33 KIF26B EXPH5 COBLL1 WNK1 MEF2D CEP350 USF3 MAP4K5 ATF7IP NAV3 CPLANE1 MGA TNS1

6.95e-094861821620936779
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

TANC2 STRN3 CRTC3 MARK1 TNRC6B R3HDM2 WNK1 AURKA FAM193A TBC1D22A STRN4 CTNNB1 AMOTL2 R3HDM1 PATJ

1.58e-084461821524255178
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

IRF2BP2 SATB2 HIVEP1 IRF2BP1 RBM33 QRICH1 FOXJ3 MEF2D GATAD2B SEPTIN6 PHF21A HNRNPL AURKA TRIM33 ZC3H10 BPTF KMT2D PRRC2C NFIL3 KNL1 PML KPNB1

8.78e-0811031822234189442
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

TNIK GTPBP4 IRF2BP2 STRN3 TNRC6B WNK1 PHF21A PHC3 MRTFB FAM193A SMG7 CLMN PRRC2C ATF7IP KIAA1217 CKAP2 EPB41 KNL1 PML KPNB1

1.15e-079341822033916271
Pubmed

Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling.

NFKB1 LTBR TNFRSF1B

1.41e-073182320139367
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

CPEB2 IRF2BP2 CRTC3 IRF2BP1 RBM33 TNRC6B QRICH1 GPATCH8 MEF2D TRIM33 KMT2D SMG7 PRRC2C FAM222B

1.52e-074571821432344865
Pubmed

A census of human transcription factors: function, expression and evolution.

ALX3 SATB2 HIVEP1 HLX TSC22D2 FOXJ3 MEF2D KMT2D USF3 SATB1 NFIL3 NFKB1 SETBP1 ELF4 PAX6 ZNF160 MGA NFAT5 CRAMP1

3.44e-079081821919274049
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

TNIK RBM33 TNRC6B GPATCH8 WNK1 GATAD2B CEP350 FAM193A TBC1D22A CLMN TANC1 CKAP2 CTNNB1 R3HDM1 PATJ MGA KNL1

3.61e-077331821734672954
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

TNIK EXPH5 MINK1 GAL3ST4 ARHGEF16 BICD1 NLGN4X SIGLEC6 CSPG4 FMN2 SEMA6A TANC1 CTNNB1 PATJ EPB41

3.68e-075691821530639242
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

ANKRD35 GTPBP4 HIVEP1 ZC3H13 MIB2 ZFC3H1 PKD1L2 LINS1 THY1 PRRC2C MYLIP CPLANE1

5.12e-073611821226167880
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

HIVEP1 RBM33 WNK1 TRIM33 MRTFB SMG7 PRRC2C ATF7IP KIAA1217 TANC1 CTNNB1 PATJ KNL1 PML CDCA4

5.57e-075881821538580884
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

TNIK STRN3 TNRC6B CILK1 SEPTIN6 BICD1 CEP350 PHAF1 MRTFB SMG7 KIAA1217 NFKB1 TANC1 CKAP2 CPLANE1 MGA EPB41 KPNB1

6.33e-078531821828718761
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TNIK TANC2 GTPBP4 STRN3 ZNF618 MINK1 TNRC6B ITIH1 GATAD2B PRRC2C ATF7IP KIAA1217 STRN4 KCNMA1 SSH2 CTNNB1 MGA TNS1 KPNB1

8.30e-079631821928671696
Pubmed

Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

THSD7A NLGN4Y COBLL1 CILK1 R3HDM2 NAV3 AMOTL2

1.16e-06102182710231032
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

MARK1 POLD2 ZC3H13 GPATCH8 WNK1 FOXJ3 SEPTIN6 AURKA PHC3 CLMN FMN2 AFF1 HSD3B2 CKAP2 PATJ CPLANE1 MGA NFAT5 TNS1 PML

1.18e-0610841822011544199
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

RBM33 TNRC6B R3HDM2 FOXJ3 AURKA NDUFAF4 FAM222B R3HDM1

1.49e-06152182838360978
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

SATB2 HIVEP1 TNRC6B PHF21A PHC3 KMT2D MRTFB FAM193A SATB1 ATF7IP MGA KNL1

2.36e-064181821234709266
Pubmed

Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17.

DAZ4 DAZ1 C3

2.79e-06618231869307
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

SATB2 QRICH1 FOXJ3 MEF2D GATAD2B PHF21A HNRNPL ZBTB37 TRIM33 BPTF KMT2D SATB1 PRRC2C NFIL3 NFKB1 CTNNB1 MGA

3.01e-068571821725609649
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

RBM33 ZKSCAN8 TNRC6B WNK1 PHAF1 BPTF FAM193A TULP4 NHS MGA TNS1

3.76e-063631821114691545
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

STRN3 KIF26B TAF1C KAT6A TOM1 CEP350 PHF1 TRIM33 COL24A1 SMG7 CLMN NFKB1 STRN4 SSH2 MGA

3.90e-066891821536543142
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

IRF2BP2 SATB2 TNRC6B QRICH1 MEF2D GATAD2B PHF21A TRIM33 SATB1 SBNO1 MGA PML

4.36e-064441821234795231
Pubmed

A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

HIVEP1 HAP1 KAT6A TNRC6B R3HDM2 QRICH1 GPATCH8 WNK1 CEP350 PHAF1 ZC3H10 THY1 LTBP1 R3HDM1

4.39e-066081821416713569
Pubmed

Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.

SATB2 ZKSCAN8 PHF21A TRIM33 ATF7IP MGA PML

4.54e-06125182732891193
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

GTPBP4 ZC3H13 TAF1C PHRF1 ZKSCAN8 ZFC3H1 GPATCH8 ESCO1 GATAD2B PHF21A HNRNPL AURKA BPTF PHC3 KMT2D NFIL3 ELF4 PAX6 CKAP2 MGA KPNB1

4.69e-0612941822130804502
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

TANC2 GTPBP4 ZNF618 TAF1C KAT6A PHRF1 TNRC6B GATAD2B PHF21A TRIM33 TRIM66 BPTF ZNF469 SMG7 FMN2 TANC1 MGA KNL1 PML

7.01e-0611161821931753913
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

TANC2 IRF2BP2 CNKSR1 SATB2 MXRA5 HIVEP1 IRF2BP1 MUC16 FOXJ3 TMEM200A CEP350 KMT2D UTY KNL1

7.57e-066381821431182584
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

CRYBG2 GATAD2B PHF1 TRIM33 BPTF KMT2D PRRC2C NFKB1 CTNNB1 MUC4 PML KPNB1

7.58e-064691821227634302
Pubmed

Embryonic poly(A)-binding protein (EPAB) is required for oocyte maturation and female fertility in mice.

DAZ4 DAZ1 PABPC1L

7.74e-068182322621333
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

TANC2 THSD7A TNRC6B HNRNPL FAM193A CLMN PRRC2C KCNMA1 NAV3 FMN2 C3 NFAT5

8.61e-064751821231040226
Pubmed

Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.

CRADD CLMN PRRC2C FMN2 AFF1

8.69e-0653182523535033
Pubmed

The DNA sequence and biological annotation of human chromosome 1.

CFH ANKRD35 CRYBG2 MARK1 OR10J3 ARHGEF16 GATAD2B CEP350 ZBTB37 TRIM33 SMG7 FMN2 HSD3B2 TNFRSF1B LY9 PATJ SLFNL1 EPB41

8.84e-0610311821816710414
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

RBM33 EXPH5 TNRC6B FAM193A SMG7 KIAA1217 NHS TANC1 R3HDM1

1.12e-05263182934702444
Pubmed

Generation of a mouse model of the neurodevelopmental disorder with dysmorphic facies and distal limb anomalies syndrome.

SATB2 BPTF PAX6

1.16e-059182335604347
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

IRF2BP2 HIVEP1 RBM33 MEF2D PHF21A TRIM33 KMT2D MGA KNL1

1.30e-05268182933640491
Pubmed

Proteomic analysis of FOXP proteins reveals interactions between cortical transcription factors associated with neurodevelopmental disorders.

SATB2 GATAD2B SATB1 NFAT5

1.35e-0528182429365100
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

HIVEP1 CD164 CMYA5 KMT2E WNK1 PHF1 CLMN NFIL3 COL14A1 ZNF160 MGA KPNB1

1.35e-054971821223414517
Pubmed

Discovery and refinement of loci associated with lipid levels.

IRF2BP2 COBLL1 TOM1 R3HDM2 SBNO1 MYLIP AFF1 C3

1.66e-05211182824097068
Pubmed

Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

SATB2 TNRC6B FOXJ3 TRIM33 PRRC2C DENND5A

1.88e-05104182610470851
Pubmed

An integrated workflow for charting the human interaction proteome: insights into the PP2A system.

STRN3 CEP350 NFKB1 STRN4 KPNB1 CDCA4

1.98e-05105182619156129
Pubmed

Role of Elavl-like RNA-binding protein in retinal development and signal transduction.

NLGN4Y NLGN4X SATB1 PAX6

2.04e-0531182439307290
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

GTPBP4 HIVEP1 KAT6A ZKSCAN8 GPATCH8 FOXJ3 GATAD2B BPTF PHC3 SATB1 SBNO1 PAX6 MGA

2.12e-056081821336089195
Pubmed

Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.

TNRC6B MIB2 SMG7 CNOT9 TTC31 PRRC2C

2.21e-05107182630995489
Pubmed

Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus.

SATB1 PML

2.72e-052182217173041
Pubmed

The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity.

CFH C3

2.72e-052182219549636
Pubmed

Wnt/β-catenin aids in regulating the proliferation of hepG2 cells mediated by thy-1.

THY1 CTNNB1

2.72e-052182225061736
Pubmed

MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.

CTNNB1 MUC4

2.72e-052182224374017
Pubmed

Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity.

NFKB1 NFAT5

2.72e-052182220685965
Pubmed

Activating β-catenin/Pax6 axis negatively regulates osteoclastogenesis by selectively inhibiting phosphorylation of p38/MAPK.

PAX6 CTNNB1

2.72e-052182230526042
Pubmed

The classical pathway triggers pathogenic complement activation in membranous nephropathy.

THSD7A C3

2.72e-052182236709213
Pubmed

Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.

NLGN4Y NLGN4X

2.72e-052182223183221
Pubmed

Characterization of four novel CAG repeat-containing cDNAs.

R3HDM2 KMT2D

2.72e-05218228595911
Pubmed

SATB1 and 2 in colorectal cancer.

SATB2 SATB1

2.72e-052182225543122
Pubmed

Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification.

CFH C3

2.72e-052182230139996
Pubmed

The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

CFH C3

2.72e-052182219454698
Pubmed

Energetic evaluation of binding modes in the C3d and Factor H (CCP 19-20) complex.

CFH C3

2.72e-052182225628052
Pubmed

TNF-α inhibits SATB2 expression and osteoblast differentiation through NF-κB and MAPK pathways.

SATB2 NFKB1

2.72e-052182229435145
Pubmed

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy.

CFH C3

2.72e-052182221435440
Pubmed

Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling.

CD14 C3

2.72e-052182231955888
Pubmed

Zinc-induced self-association of complement C3b and Factor H: implications for inflammation and age-related macular degeneration.

CFH C3

2.72e-052182223661701
Pubmed

Unusually rapid evolution of Neuroligin-4 in mice.

NLGN4Y NLGN4X

2.72e-052182218434543
Pubmed

PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription.

CTNNB1 PML

2.72e-052182212384561
Pubmed

Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.

NLGN4Y NLGN4X

2.72e-052182237080762
Pubmed

Interactions between β-catenin and the HSlo potassium channel regulates HSlo surface expression.

KCNMA1 CTNNB1

2.72e-052182222194818
Pubmed

Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.

NLGN4Y NLGN4X

2.72e-052182229106499
Pubmed

Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.

NLGN4Y NLGN4X

2.72e-052182226456829
Pubmed

Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.

NLGN4Y NLGN4X

2.72e-052182224104404
Pubmed

TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2.

NFKB1 TNFRSF1B

2.72e-052182225152365
Pubmed

Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.

NLGN4Y NLGN4X

2.72e-052182222989184
Pubmed

Structural basis for engagement by complement factor H of C3b on a self surface.

CFH C3

2.72e-052182221317894
Pubmed

AMOTL2‑knockdown promotes the proliferation, migration and invasion of glioma by regulating β‑catenin nuclear localization.

CTNNB1 AMOTL2

2.72e-052182234036399
Pubmed

Altered expression of MLL methyltransferase family genes in breast cancer.

KMT2E KMT2D

2.72e-052182223754336
Pubmed

Regulation of dendritic spines, spatial memory, and embryonic development by the TANC family of PSD-95-interacting proteins.

TANC2 TANC1

2.72e-052182221068316
Pubmed

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.

SATB2 SATB1

2.72e-052182225323550
Pubmed

The transcriptional cofactor MCAF1/ATF7IP is involved in histone gene expression and cellular senescence.

ATF7IP PML

2.72e-052182223935871
Pubmed

CD14-dependent activation of NF-kappaB by filarial parasitic sheath proteins.

CD14 NFKB1

2.72e-052182211779220
Pubmed

Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count.

CFH C3

2.72e-052182219703145
Pubmed

Formin-2, a novel formin homology protein of the cappuccino subfamily, is highly expressed in the developing and adult central nervous system.

FMN2 PAX6

2.72e-052182210781961
Pubmed

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).

CFH C3

2.72e-052182216612335
Pubmed

The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.

CFH C3

2.72e-052182219112495
Pubmed

Cooperative role of lymphotoxin β receptor and tumor necrosis factor receptor p55 in murine liver regeneration.

LTBR TNFRSF1B

2.72e-052182226708145
Pubmed

Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese population.

CFH C3

2.72e-052182219850835
Pubmed

Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.

NLGN4Y NLGN4X

2.72e-052182224855039
Pubmed

Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.

NLGN4Y NLGN4X

2.72e-052182237001827
Pubmed

Aurora-A/NF-ĸB Signaling Is Associated With Radio-resistance in Human Lung Adenocarcinoma.

AURKA NFKB1

2.72e-052182231704824
Pubmed

Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy.

CFH C3

2.72e-052182220841369
Pubmed

Karyopherinβ1 regulates proliferation of human glioma cells via Wnt/β-catenin pathway.

CTNNB1 KPNB1

2.72e-052182227568288
Pubmed

Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.

MUC16 MUC4

2.72e-052182223544943
Pubmed

Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway.

AURKA NFKB1

2.72e-052182221623171
Pubmed

Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.

SATB2 CTNNB1

2.72e-052182228438615
Pubmed

Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB.

MUC16 NFKB1

2.72e-052182226918940
InteractionSMG7 interactions

IRF2BP2 HIVEP1 RBM33 TNRC6B R3HDM2 GPATCH8 MEF2D HNRNPL BICD1 TRIM66 KMT2D FAM193A SMG7 CNOT9 R3HDM1

1.78e-0731917915int:SMG7
InteractionFHL2 interactions

QRICH1 WNK1 GATAD2B PHF21A PHF1 PHC3 MRTFB CNOT9 PRRC2C SIGLEC6 KIAA1217 CTNNB1 PATJ NFAT5 KNL1 PML

5.27e-0739617916int:FHL2
InteractionDAZL interactions

RBM33 DAZ4 TNRC6B R3HDM2 DAZ1 HNRNPL SMG7 CNOT9 PRRC2C R3HDM1

6.96e-0714517910int:DAZL
InteractionALG13 interactions

RBM33 TNRC6B R3HDM2 GPATCH8 ZC3H10 TRIM66 KMT2D SMG7 CNOT9 PRRC2C R3HDM1

7.56e-0718317911int:ALG13
InteractionCNOT9 interactions

STRN3 MINK1 TNRC6B R3HDM2 CEP350 AURKA FAM193A SMG7 CNOT9 PRRC2C STRN4 MGA

1.11e-0623117912int:CNOT9
InteractionSP2 interactions

KAT6A QRICH1 HECW2 ELF4 TNFRSF1B PML

1.15e-06391796int:SP2
InteractionNUP35 interactions

CPEB2 IRF2BP2 CRTC3 IRF2BP1 RBM33 TNRC6B QRICH1 GPATCH8 MEF2D PHAF1 TRIM33 KMT2D SMG7 PRRC2C FAM222B KPNB1

1.29e-0642417916int:NUP35
InteractionZYX interactions

TANC2 TNRC6B QRICH1 TSC22D2 WNK1 PHF21A CEP350 PLEKHG4B SMG7 CLMN KIAA1217 TANC1 SSH2 PML

1.52e-0632917914int:ZYX
InteractionYWHAH interactions

TANC2 CRTC3 HIVEP1 REM1 KIF26B MARK1 EXPH5 ZC3H13 COBLL1 MINK1 R3HDM2 WNK1 ARHGEF16 MEF2D CEP350 CLMN PRRC2C KIAA1217 KCNMA1 FMN2 NHS TANC1 SSH2 AMOTL2 R3HDM1 PATJ EPB41

1.59e-06110217927int:YWHAH
InteractionYWHAG interactions

TANC2 GTPBP4 CRTC3 HIVEP1 KIF26B MARK1 EXPH5 ZC3H13 COBLL1 MINK1 R3HDM2 WNK1 ARHGEF16 MEF2D CEP350 DLC1 CLMN MAP4K5 PRRC2C KCNMA1 FMN2 NHS TANC1 SSH2 CKAP2 AMOTL2 R3HDM1 PATJ EPB41

1.80e-06124817929int:YWHAG
InteractionBAG2 interactions

TNIK IRF2BP2 IRF2BP1 RBM33 EXPH5 QRICH1 ZFC3H1 WNK1 MEF2D TRIM33 TRIM66 BPTF PHC3 MRTFB PRRC2C CKAP2 R3HDM1 KNL1 PML

2.97e-0662217919int:BAG2
InteractionKDM1A interactions

TNIK SATB2 HIVEP1 TNRC6B ESCO1 MEF2D SEPTIN6 PHF21A CEP350 PHF1 PHC3 KMT2D MRTFB FAM193A SMG7 SATB1 ATF7IP KIAA1217 MYLIP CTNNB1 MGA KNL1 PHF13 CDCA4

3.26e-0694117924int:KDM1A
InteractionCNOT2 interactions

MINK1 TNRC6B R3HDM2 AURKA FAM193A SMG7 CNOT9 PRRC2C NFKB1 CTNNB1

4.47e-0617817910int:CNOT2
InteractionKLF3 interactions

IRF2BP2 SATB2 HIVEP1 IRF2BP1 MEF2D GATAD2B PHF21A BPTF KMT2D ATF7IP MGA

6.40e-0622817911int:KLF3
InteractionCPEB1 interactions

TNRC6B R3HDM2 HNRNPL AURKA SMG7 CNOT9 TTC31 PRRC2C R3HDM1

6.40e-061461799int:CPEB1
InteractionE2F3 interactions

CFH SATB2 WNK1 HNRNPL KMT2D MGA PML

6.56e-06791797int:E2F3
InteractionHNF4A interactions

IRF2BP2 SATB2 HIVEP1 IRF2BP1 STK16 TRIM33 BPTF KMT2D ATF7IP CTNNB1 MGA PML

6.74e-0627517912int:HNF4A
InteractionTLE3 interactions

IRF2BP2 CRTC3 HIVEP1 HLX QRICH1 GPATCH8 HNRNPL PHC3 KMT2D FAM193A SMG7 PAX6 CTNNB1 KNL1

7.11e-0637617914int:TLE3
InteractionHNF1B interactions

SATB2 HIVEP1 MEF2D BPTF KMT2D SATB1 ATF7IP PAX6 CTNNB1 MGA

7.96e-0619017910int:HNF1B
InteractionCPEB4 interactions

CPEB2 TNRC6B R3HDM2 TRIM66 FAM193A SMG7 CNOT9 PRRC2C R3HDM1

1.10e-051561799int:CPEB4
InteractionSOX6 interactions

IRF2BP2 SATB2 IRF2BP1 RBM33 MEF2D GATAD2B SATB1 PRRC2C CTNNB1

1.15e-051571799int:SOX6
InteractionNUP43 interactions

HIVEP1 ZC3H13 PHRF1 TNRC6B CCDC168 ZFC3H1 GPATCH8 PHF21A BPTF PHC3 KMT2D MRTFB PRRC2C ATF7IP ELF4 MGA KNL1 KPNB1

1.22e-0562517918int:NUP43
InteractionLHX4 interactions

GTPBP4 SATB2 HIVEP1 QRICH1 MEF2D TRIM33 KMT2D SATB1 MGA

1.80e-051661799int:LHX4
InteractionSHPRH interactions

KAT6A GATAD2B HNRNPL PHF1 BPTF NFAT5 PML

2.54e-05971797int:SHPRH
InteractionTEAD1 interactions

IRF2BP2 SATB2 HIVEP1 IRF2BP1 MEF2D BPTF KMT2D SATB1 MGA

2.86e-051761799int:TEAD1
InteractionHDAC2 interactions

TNIK IRF2BP2 CRTC3 SATB2 HLX WNK1 ARHGEF16 ESCO1 GATAD2B PHF21A PHF1 AURKA BPTF SATB1 PRRC2C NFKB1 COL14A1 LTBP1 CTNNB1 PML KPNB1

2.93e-0586517921int:HDAC2
InteractionTNRC6C interactions

TNRC6B R3HDM2 MIB2 HNRNPL BICD1 AURKA SMG7 CNOT9

3.29e-051381798int:TNRC6C
InteractionFOXK2 interactions

TANC2 SATB2 KAT6A MEF2D HNRNPL BPTF KMT2D PRRC2C HECW2 PAX6

3.43e-0522517910int:FOXK2
InteractionSRF interactions

HIVEP1 GATAD2B HNRNPL BPTF PHC3 MRTFB NFKB1 PML

3.47e-051391798int:SRF
InteractionZFP36 interactions

TNRC6B R3HDM2 FAM193A SMG7 CNOT9 TTC31 PRRC2C NFKB1 R3HDM1

3.57e-051811799int:ZFP36
InteractionCNOT7 interactions

MINK1 TNRC6B R3HDM2 AURKA FAM193A SMG7 CNOT9 NFKB1

3.65e-051401798int:CNOT7
InteractionNFIX interactions

IRF2BP2 SATB2 HIVEP1 IRF2BP1 QRICH1 HNRNPL BPTF KMT2D PAX6 MGA

3.70e-0522717910int:NFIX
InteractionLHX1 interactions

GTPBP4 SATB2 HIVEP1 MEF2D KMT2D SATB1 MGA

3.75e-051031797int:LHX1
InteractionTNIK interactions

TNIK TANC2 GTPBP4 STRN3 MINK1 GATAD2B BICD1 KIAA1217 STRN4 KCNMA1 LTBR CTNNB1 MGA

3.79e-0538117913int:TNIK
InteractionKLF8 interactions

GTPBP4 HIVEP1 SLC5A9 MEF2D PHF21A HNRNPL TRIM33 BPTF KMT2D PRRC2C ATF7IP MGA

3.99e-0532917912int:KLF8
InteractionFAM193A interactions

TNRC6B PHF21A FAM193A SMG7 CNOT9 CTNNB1

4.01e-05711796int:FAM193A
InteractionCEP120 interactions

HLX TNRC6B BICD1 CEP350 LTBR CKAP2 KNL1

4.51e-051061797int:CEP120
InteractionTNRC6B interactions

KAT6A TNRC6B R3HDM2 PHF21A HNRNPL BICD1 AURKA FAM193A SMG7 CNOT9 PML

4.60e-0528217911int:TNRC6B
InteractionSFN interactions

TNIK TANC2 CRTC3 KIF26B MARK1 EXPH5 COBLL1 MINK1 WNK1 ARHGEF16 CEP350 CLMN PRRC2C FMN2 NHS TANC1 SSH2 CTNNB1

4.67e-0569217918int:SFN
InteractionKLF10 interactions

IRF2BP2 HIVEP1 IRF2BP1 TNS1 PML

4.79e-05451795int:KLF10
InteractionFAM120C interactions

TNRC6B R3HDM2 HNRNPL TRIM66 FAM193A SMG7 CNOT9 PRRC2C R3HDM1

5.43e-051911799int:FAM120C
InteractionYWHAQ interactions

TANC2 CRTC3 REM1 KIF26B MARK1 EXPH5 ZC3H13 COBLL1 MINK1 R3HDM2 WNK1 ARHGEF16 MEF2D HNRNPL CEP350 NFKB1 KCNMA1 NHS TANC1 SSH2 CTNNB1 AMOTL2 R3HDM1 EPB41

5.52e-05111817924int:YWHAQ
InteractionMAPRE1 interactions

GPR137 TANC2 GTPBP4 ARHGEF16 BICD1 CEP350 AURKA PRRC2C KIAA1217 NAV3 TANC1 PAX6 CKAP2 CTNNB1 KPNB1

5.77e-0551417915int:MAPRE1
InteractionMGA interactions

TNIK CFH CRYBG2 ARHGEF16 PHF21A CNOT9 ELF4 LTBR PAX6 MGA

5.92e-0524017910int:MGA
InteractionELF4 interactions

TRIM33 BPTF KMT2D ATF7IP ELF4 MGA PML

7.58e-051151797int:ELF4
InteractionSP7 interactions

IRF2BP2 SATB2 HIVEP1 IRF2BP1 RBM33 GPATCH8 MEF2D TRIM33 KMT2D SATB1 MGA

9.02e-0530417911int:SP7
InteractionNIN interactions

TNRC6B CILK1 BICD1 CEP350 AURKA TRIM33 SMG7 KIAA1217 TANC1 CKAP2 CPLANE1 MGA

9.19e-0535917912int:NIN
InteractionYWHAB interactions

TANC2 CRTC3 HIVEP1 KIF26B MARK1 EXPH5 COBLL1 MINK1 KAT6A R3HDM2 WNK1 ARHGEF16 CEP350 TRIM33 TBC1D22A KCNMA1 NHS TANC1 SSH2 AMOTL2 R3HDM1 EPB41

9.93e-05101417922int:YWHAB
InteractionQPRT interactions

SATB2 IRF2BP1 GATAD2B TRIM33 SATB1 PRRC2C

1.03e-04841796int:QPRT
InteractionPAX6 interactions

IRF2BP2 SATB2 HIVEP1 QRICH1 PHF21A BPTF KMT2D SATB1 SIGLEC6 PAX6 PATJ MGA

1.10e-0436617912int:PAX6
InteractionPEX5L interactions

TNIK TANC2 ACVRL1 KIAA1217 CTNNB1

1.16e-04541795int:PEX5L
InteractionUSP54 interactions

TNRC6B R3HDM2 QRICH1 IQCN BICD1 STK16 PHF1 TRIM66 CTNNB1

1.21e-042121799int:USP54
InteractionJMJD1C interactions

GTPBP4 PHF21A HNRNPL SMG7 CNOT9 PML

1.34e-04881796int:JMJD1C
InteractionZC3H7A interactions

TNRC6B R3HDM2 MIB2 FAM193A SMG7 CNOT9 TTC31 PRRC2C R3HDM1

1.34e-042151799int:ZC3H7A
InteractionKMT2D interactions

MEF2D PHF21A KMT2D SMG7 ELF4 PAX6 CTNNB1 UTY

1.37e-041691798int:KMT2D
InteractionPCM1 interactions

TNIK HAP1 PHF21A HNRNPL BICD1 CEP350 AURKA SMG7 CNOT9 KIAA1217 STRN4 TANC1 CKAP2

1.41e-0443417913int:PCM1
InteractionZMYM2 interactions

TNIK SATB2 ZKSCAN8 TSC22D2 PHF21A TRIM33 ATF7IP PAX6 MGA PML

1.61e-0427117910int:ZMYM2
InteractionPIAS4 interactions

IRF2BP2 TAF1C HNRNPL SATB1 ATF7IP MGA PML KPNB1

1.61e-041731798int:PIAS4
InteractionMEX3B interactions

CPEB2 TNRC6B R3HDM2 ACVRL1 FAM193A SMG7 CNOT9 PRRC2C R3HDM1

1.71e-042221799int:MEX3B
InteractionGATAD1 interactions

GPATCH8 GATAD2B PHF1 BPTF HECW2 ELF4 PAX6

1.72e-041311797int:GATAD1
InteractionTLX1 interactions

IRF2BP2 SATB2 HIVEP1 IRF2BP1 KAT6A MEF2D KMT2D SATB1

1.74e-041751798int:TLX1
InteractionCNOT6L interactions

MINK1 TNRC6B FAM193A SMG7 CNOT9 NFKB1

1.82e-04931796int:CNOT6L
InteractionFHL3 interactions

TANC2 THSD7A QRICH1 WNK1 PHF21A PLEKHG4B TRIM33 MRTFB FAM222B PML

1.87e-0427617910int:FHL3
InteractionH3-4 interactions

KAT6A PHRF1 PHF21A HNRNPL PHF1 AURKA BPTF PHC3 USF3 PRRC2C AFF1 MGA KPNB1

1.92e-0444817913int:H3-4
InteractionPPP3R2 interactions

TMEM200A AURKA DLC1 CD14

2.01e-04331794int:PPP3R2
InteractionTNRC6A interactions

TNRC6B R3HDM2 MIB2 WNK1 PHF21A BICD1 TRIM66 FAM193A SMG7 CNOT9

2.10e-0428017910int:TNRC6A
InteractionLHX2 interactions

GTPBP4 SATB2 HIVEP1 MEF2D KMT2D SATB1 PAX6 MGA

2.37e-041831798int:LHX2
InteractionPML interactions

IRF2BP2 IRF2BP1 KAT6A TNRC6B QRICH1 ARHGEF16 MEF2D GATAD2B PHF21A AURKA TRIM33 TRIM66 SATB1 SBNO1 ATF7IP NFKB1 ELF4 CTNNB1 KNL1 PML

2.45e-0493317920int:PML
InteractionPHF21A interactions

HIVEP1 TNRC6B PHF21A KMT2D MRTFB FAM193A CD14 PAX6 MGA KNL1 PML

2.58e-0434317911int:PHF21A
InteractionOTUD4 interactions

TNRC6B R3HDM2 IQCN SMG7 CNOT9 TTC31 PRRC2C CKAP2 R3HDM1

2.69e-042361799int:OTUD4
InteractionZBTB16 interactions

CFH HNRNPL PHF1 PHAF1 SATB1 MYLIP AMOTL2 PML

2.74e-041871798int:ZBTB16
InteractionPAN3 interactions

TNRC6B R3HDM2 HNRNPL BICD1 CNOT9

2.81e-04651795int:PAN3
InteractionNFIB interactions

IRF2BP2 SATB2 HIVEP1 IRF2BP1 HNRNPL KMT2D PAX6

2.82e-041421797int:NFIB
InteractionPRR20E interactions

HIVEP1 HLX PHF1 ZC3H10 ATF7IP FAM222B

2.85e-041011796int:PRR20E
InteractionSALL1 interactions

GATAD2B PHF21A SMG7 CNOT9 PAX6 CTNNB1

3.00e-041021796int:SALL1
InteractionDLG1 interactions

TNIK KIF26B ARHGEF16 HNRNPL TULP4 TANC1 PAX6 CTNNB1 EPB41

3.04e-042401799int:DLG1
InteractionYWHAE interactions

TANC2 CRTC3 HIVEP1 REM1 KIF26B MARK1 EXPH5 COBLL1 MINK1 R3HDM2 WNK1 ARHGEF16 HNRNPL KCNMA1 NHS LTBP1 TANC1 SSH2 CTNNB1 AMOTL2 R3HDM1 MGA EPB41 KPNB1

3.21e-04125617924int:YWHAE
InteractionSPI1 interactions

KAT6A AURKA TRIM33 NFKB1 PML

3.23e-04671795int:SPI1
InteractionKDM3A interactions

IRF2BP1 MRTFB NAV3 CCDC158 PML

3.23e-04671795int:KDM3A
InteractionCEP192 interactions

TNRC6B R3HDM2 HNRNPL BICD1 CEP350 AURKA CNOT9 KPNB1

3.27e-041921798int:CEP192
InteractionCHD8 interactions

TNIK ZC3H13 PHF21A SMG7 CTNNB1 MGA PML KPNB1

3.39e-041931798int:CHD8
InteractionSOX2 interactions

GTPBP4 IRF2BP2 SATB2 HIVEP1 IRF2BP1 MARK1 TOM1 MEF2D ITIH1 GATAD2B HNRNPL MRPL39 TRIM33 BPTF PHC3 KMT2D SATB1 KIAA1217 NAV3 C3 PAX6 CKAP2 CTNNB1 AMOTL2 CPLANE1 KNL1

3.52e-04142217926int:SOX2
InteractionYTHDF3 interactions

TNRC6B R3HDM2 FAM193A SMG7 CNOT9 PRRC2C HECW2 R3HDM1 PML

3.65e-042461799int:YTHDF3
InteractionZHX2 interactions

HNRNPL NFKB1 ELF4 PAX6 PML

3.71e-04691795int:ZHX2
InteractionNLK interactions

QRICH1 HNRNPL FAM222B CTNNB1 KPNB1

3.97e-04701795int:NLK
InteractionFOXP2 interactions

TNIK SATB2 GATAD2B SATB1 NFAT5

3.97e-04701795int:FOXP2
InteractionASF1A interactions

IRF2BP2 HIVEP1 ZC3H13 MEF2D GATAD2B TRIM33 KMT2D MGA PML

3.98e-042491799int:ASF1A
InteractionNR3C1 interactions

TANC2 IRF2BP2 STRN3 CNKSR1 SATB2 MXRA5 HIVEP1 IRF2BP1 MUC16 FOXJ3 TMEM200A CEP350 KMT2D NFKB1 C3 CTNNB1 UTY KNL1 PML KPNB1

4.26e-0497417920int:NR3C1
InteractionSTARD10 interactions

STRN3 HNRNPL STRN4

4.28e-04171793int:STARD10
InteractionPRR20A interactions

HIVEP1 HLX PHF1 ZC3H10 ATF7IP FAM222B

4.29e-041091796int:PRR20A
InteractionMAD2L1 interactions

HIVEP1 KAT6A AURKA TRIM33 BPTF MAP4K5 ATF7IP CKAP2 MGA

4.35e-042521799int:MAD2L1
InteractionNAA40 interactions

TNIK GTPBP4 IRF2BP2 STRN3 TNRC6B WNK1 PHF21A PHC3 MRTFB FAM193A SMG7 CLMN PRRC2C ATF7IP KIAA1217 CKAP2 EPB41 KNL1 PML KPNB1

4.49e-0497817920int:NAA40
InteractionPHF12 interactions

GPATCH8 GATAD2B PHF21A BPTF ELF4 PAX6

4.51e-041101796int:PHF12
InteractionCTTNBP2NL interactions

TNIK STRN3 MINK1 STRN4 PML

4.52e-04721795int:CTTNBP2NL
InteractionERV3-1 interactions

HNRNPL HECW2

4.65e-0441792int:ERV3-1
InteractionLINC01194 interactions

HNRNPL CTNNB1

4.65e-0441792int:LINC01194
InteractionPAX8 interactions

SATB2 HIVEP1 IRF2BP1 MEF2D AURKA KMT2D

4.73e-041111796int:PAX8
InteractionFEV interactions

SATB2 HIVEP1 GPATCH8 PHF21A PHC3 KMT2D SATB1 MGA

4.74e-042031798int:FEV
InteractionFOXP1 interactions

SATB2 GATAD2B HNRNPL AURKA SATB1 PAX6 CTNNB1 TNFRSF1B NFAT5

4.87e-042561799int:FOXP1
InteractionRCOR1 interactions

TNIK SATB2 HIVEP1 TNRC6B PHF21A TRIM66 KMT2D MRTFB FAM193A SATB1 MGA KNL1 PHF13

4.89e-0449417913int:RCOR1
GeneFamilyPHD finger proteins

KAT6A PHRF1 KMT2E PHF21A PHF1 TRIM33 TRIM66 BPTF KMT2D PHF13

3.23e-10901171088
GeneFamilyProtein phosphatase catalytic subunits|STRIPAK complex

STRN3 MINK1 STRN4

2.78e-042011731371
GeneFamilyCUT class homeoboxes and pseudogenes

SATB2 SATB1

1.45e-0391172527
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

STRN3 SATB2 HIVEP1 CRADD KAT6A R3HDM2 TSC22D2 GPATCH8 FOXJ3 PHF21A BICD1 CEP350 AURKA TRIM33 BPTF FAM193A DLC1 MAP4K5 PRRC2C NFKB1 NAV3 AFF1 DENND5A R3HDM1

5.50e-0985618024M4500
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

STRN3 SATB2 HIVEP1 CRADD KAT6A R3HDM2 FOXJ3 PHF21A CEP350 TRIM33 BPTF DLC1 MAP4K5 PRRC2C AFF1 DENND5A R3HDM1

2.62e-0846618017M13522
CoexpressionGSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN

TNIK CRTC3 HIVEP1 CCDC110 KAT6A GAL3ST4 BPTF USF3 SSH2 DENND5A NFAT5

8.38e-0818918011M3112
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

WNK1 CEP350 ZBTB37 TRIM33 BPTF TULP4 SBNO1 PRRC2C ATF7IP NFAT5

5.06e-0718018010M8239
CoexpressionACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP

TNIK TANC2 MARK1 BICD1 DLC1 SEMA6D SATB1 HECW2 KIAA1217 NAV3 FMN2 MGA

8.54e-0729018012M11616
CoexpressionGSE2585_CTEC_VS_THYMIC_DC_DN

CFH HAP1 GAL3ST4 PKD1L2 COL24A1 NFKB1 COL14A1 CPLANE1 MARCHF11 PML

1.32e-0620018010M6272
CoexpressionKINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN

TANC2 KIF26B TNRC6B MEF2D SEPTIN6 DLC1 SATB1 TBC1D22A KIAA1217 MYLIP AFF1 AMOTL2

4.05e-0633718012M13206
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

EXPH5 KAT6A ZFC3H1 FOXJ3 CEP350 AURKA BPTF SATB1 NFKB1 NAV3 AFF1

7.83e-0630018011M8702
CoexpressionGSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP

IRF2BP2 RBM33 MEF2D STK16 USF3 MYLIP DENND5A CKAP2 CRAMP1

9.41e-061971809M4167
CoexpressionESC_V6.5_UP_EARLY.V1_UP

TNRC6B ARHGEF16 GATAD2B PHF21A DLC1 SATB1 TNFRSF1B MGA

2.03e-051661808M2770
CoexpressionNAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN

CPEB2 IRF2BP2 RBM33 ZFC3H1 TSC22D2 ESCO1 MEF2D USF3 NFIL3 CTNNB1

2.26e-0527618010M41128
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

CPEB2 TANC2 THSD7A MARK1 ZKSCAN8 TNRC6B CILK1 FAM193A SEMA6D TULP4 TBC1D22A CLMN MAP4K5 PRRC2C NAV3 FMN2 LTBP1 DENND5A AMOTL2 DEPDC7 TNS1

2.41e-05110218021M2369
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN

TSC22D2 GPATCH8 BICD1 FAM193A NFKB1 NAV3

2.69e-05851806M10575
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

CPEB2 TANC2 THSD7A MARK1 ZKSCAN8 TNRC6B CILK1 FAM193A SEMA6D TULP4 TBC1D22A CLMN MAP4K5 PRRC2C NAV3 FMN2 LTBP1 DENND5A AMOTL2 DEPDC7 TNS1

3.22e-05112418021MM1070
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

RBM33 KAT6A TNRC6B ZFC3H1 GPATCH8 KMT2E WNK1 FOXJ3 MEF2D GATAD2B SEPTIN6 CEP350 TRIM33 BPTF PHC3 KMT2D SBNO1 ATF7IP MYLIP SSH2 CKAP2 TNFRSF1B LY9 NFAT5 KPNB1

3.35e-05149218025M40023
CoexpressionGSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN

CCDC168 KMT2E BPTF PHC3 MRTFB AMOTL2 MUC4 EPB41

5.72e-051921808M6064
CoexpressionGSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN

COBLL1 CD164 APOL1 LINS1 SBNO1 AFF1 C3 CAPN5

7.10e-051981808M3267
CoexpressionGSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN

ZFC3H1 MEF2D PHAF1 KMT2D MRTFB STRN4 TANC1 NFAT5

7.35e-051991808M7319
CoexpressionGSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP

CPEB2 SEMA6D SATB1 CD14 NFIL3 PATJ EPB41 PML

7.35e-051991808M6895
CoexpressionGSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN

STRN3 HLX CEP350 TBC1D22A NFIL3 C3 DENND5A KPNB1

7.61e-052001808M9625
CoexpressionGSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN

HLX WNK1 ESCO1 KMT2D SBNO1 SSH2 LY9 NFAT5

7.61e-052001808M7150
CoexpressionGSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP

CACNA1F POLD2 TAF1C WNK1 GATAD2B TBC1D22A CLMN DEPDC7

7.61e-052001808M4143
CoexpressionGSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP

TNIK EXPH5 MEF2D MRTFB FAM193A SATB1 TULP4 MAP4K5

7.61e-052001808M9203
CoexpressionGSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN

IRF2BP2 QRICH1 TSC22D2 MEF2D SATB1 MYLIP AFF1 PHF13

7.61e-052001808M4318
CoexpressionLEE_DIFFERENTIATING_T_LYMPHOCYTE

RBM33 KMT2E SEPTIN6 CEP350 USF3 SATB1 ZNF160 EPB41

7.88e-052011808M2200
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN

CD164 R3HDM2 KMT2D PRRC2C MYLIP AFF1 R3HDM1

1.10e-041571807M7733
CoexpressionPICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP

CFH MXRA5 ACVRL1 THY1 KCNMA1 C3 TANC1 TNS1

1.10e-042111808M12225
CoexpressionLAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2

CRADD ZC3H13 TNRC6B PRRC2C SETBP1 NHS PATJ TNS1

1.52e-042211808M39222
CoexpressionGSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN

HAP1 WNK1 ZBTB37 PHC3 CLMN R3HDM1 NFAT5

1.55e-041661807M6826
CoexpressionDESCARTES_ORGANOGENESIS_CHOLINERGIC_NEURONS

TANC2 DLC1 SEMA6D HECW2 MARCHF11

1.80e-04761805MM3658
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000

ALX3 CPEB2 TNIK IRF2BP2 SATB2 THSD7A KIF26B MARK1 ZKSCAN8 CILK1 GAL3ST4 KMT2E FOXJ3 GATAD2B CEP350 COL24A1 FAM193A DLC1 MYLIP NAV3 FMN2 LTBP1 CPLANE1 NFAT5 KPNB1

6.04e-0976917725gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000

TANC2 IRF2BP2 ZNF618 ZKSCAN8 TNRC6B WNK1 GATAD2B PHF21A CEP350 ZBTB37 FAM193A DLC1 TULP4 SBNO1 COL14A1 CPLANE1 KPNB1

2.59e-0838517717gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000

CPEB2 TANC2 IRF2BP2 THSD7A KIF26B MARK1 ZNF618 ZKSCAN8 TNRC6B WNK1 GATAD2B PHF21A CEP350 ZBTB37 FAM193A DLC1 TULP4 SBNO1 KCNMA1 FMN2 COL14A1 LTBP1 CPLANE1 KPNB1

8.65e-0881817724gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500

IRF2BP2 ZNF618 ZKSCAN8 TNRC6B GATAD2B CEP350 DLC1 COL14A1 CPLANE1 KPNB1

1.06e-0520917710gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500

IRF2BP2 KIF26B ZNF618 ZKSCAN8 TNRC6B GATAD2B CEP350 DLC1 KCNMA1 FMN2 COL14A1 LTBP1 CPLANE1 KPNB1

1.09e-0541617714gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000

TANC2 IRF2BP2 MARK1 ZKSCAN8 CEP350 ZBTB37 DLC1 SBNO1 COL14A1 CPLANE1 NFAT5 KPNB1

2.22e-0533017712DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000

CFH ZNF618 ZC3H13 KMT2E ESCO1 TULP4 CLMN PRRC2C KIAA1217 LRRTM4 COL14A1 CTNNB1 R3HDM1 CPLANE1 MGA NFAT5 TNS1 UTY KNL1

3.49e-0579017719gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200

IRF2BP2 ZKSCAN8 DLC1 COL14A1 CPLANE1 KPNB1

4.82e-05781776gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000

CPEB2 TANC2 IRF2BP2 KIF26B MARK1 ZKSCAN8 GAL3ST4 CEP350 ZBTB37 DLC1 SBNO1 MAP4K5 PRRC2C LRRTM4 KCNMA1 COL14A1 CPLANE1 NFAT5 KPNB1

5.57e-0581817719DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlasFacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000

TNIK HAP1 KIF26B GAL3ST4 MIB2 GPATCH8 PHF21A PHF1 COL24A1 FNDC1 TULP4 HECW2 SETBP1 CSPG4 LRRTM4 NAV3 FMN2 COL14A1 PAX6 PATJ MUC4

6.39e-0597317721Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000

IRF2BP2 ZKSCAN8 GATAD2B CEP350 FAM193A DLC1 NAV3 CPLANE1 KPNB1

6.71e-052091779gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000

ALX3 TANC2 IRF2BP2 THSD7A KIF26B ZKSCAN8 CILK1 GAL3ST4 COL24A1 DLC1 SATB1 TULP4 MAP4K5 HECW2 LRRTM4 FMN2 COL14A1 LTBP1 UTY

7.43e-0583617719gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000

ALX3 TNIK SATB2 THSD7A KIF26B MARK1 CILK1 GAL3ST4 FOXJ3 COL24A1 FMN2 LTBP1

8.04e-0537717712gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000

IRF2BP2 ZKSCAN8 ZBTB37 DLC1 COL14A1 CPLANE1 NFAT5 KPNB1

1.27e-041781778DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000

TNIK CFH ZC3H13 COBLL1 KMT2E ESCO1 FNDC1 CLMN PRRC2C KIAA1217 COL14A1 C3 R3HDM1 CPLANE1 MGA TNS1 UTY KNL1

1.29e-0479917718gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlaskidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_100

CFH C3

2.06e-0431772gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_100
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500

GATAD2B CEP350 ZBTB37 FAM193A CPLANE1 NFAT5 KPNB1

2.58e-041491777gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500

ALX3 IRF2BP2 KIF26B GAL3ST4 COL24A1 SATB1 MAP4K5 HECW2 LRRTM4 COL14A1 LTBP1 UTY

2.67e-0442917712gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000

CFH ZC3H13 KMT2E WNK1 ESCO1 TRIM66 SATB1 TULP4 SBNO1 PRRC2C LRRTM4 HSD3B2 R3HDM1 CPLANE1 MGA NFAT5 CCDC158

2.86e-0477817717gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1

CRADD RBM33 ZKSCAN8 TNRC6B CILK1 R3HDM2 KIAA1614 TEX48 USF3 MRTFB FAM193A NFKB1 STRN4 R3HDM1 CPLANE1 ZNF454 EPB41

2.94e-0478017717Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000

MARK1 GPATCH8 GATAD2B CEP350 ZBTB37 FAM193A CPLANE1 NFAT5 EPB41 KPNB1

3.01e-0431217710gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlasDevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000

CPEB2 ZKSCAN8 PRRC2C FMN2 R3HDM1 CPLANE1 NFAT5 KNL1

3.12e-042031778gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5
CoexpressionAtlasdev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_1000

CPEB2 TNIK NFIL3 KIAA1217 COL14A1 ELF4 UTY

3.41e-041561777gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_1000
CoexpressionAtlasdev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000

CPEB2 TANC2 IRF2BP2 CRTC3 ZNF618 MUC16 FOXJ3 ESCO1 PHF21A PHAF1 SEMA6D HECW2 ATF7IP AFF1 ELF4 PATJ NFAT5

3.46e-0479117717gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000

CPEB2 IRF2BP2 SATB2 COBLL1 ARHGEF16 GATAD2B CEP350 BPTF NDUFAF4 FAM193A PRRC2C KIAA1217 COL14A1 HSD3B2 PATJ MGA NFAT5

3.66e-0479517717gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlasFacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5

TNIK TANC2 CRTC3 SATB2 KIF26B ZNF618 KMT2E PHF21A COL24A1 PHC3 THY1 MYLIP NAV3 NHS SEMA6A MUC4

3.94e-0472617716Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000

ALX3 IRF2BP2 KIF26B MARK1 ZKSCAN8 SLC5A9 FOXJ3 GATAD2B CEP350 FAM193A DLC1 SATB1 LRRTM4 KCNMA1 FMN2 CPLANE1 KPNB1

4.28e-0480617717DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlasFacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5

THSD7A HAP1 MARK1 ZNF618 MIB2 KMT2E TMEM200A PHF21A BICD1 CEP350 TULP4 SETBP1 LRRTM4 FMN2 SEMA6A PAX6

4.31e-0473217716Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500

IRF2BP2 ZKSCAN8 CEP350 DLC1 COL14A1 CPLANE1 KPNB1

4.78e-041651777DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200

KIF26B TNRC6B CEP350 KCNMA1 COL14A1 LTBP1 KPNB1

4.95e-041661777gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200
CoexpressionAtlasFacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000

ALX3 HAP1 KIF26B COBLL1 GAL3ST4 BICD1 COL24A1 FNDC1 MRTFB KIAA1217 CSPG4 LRRTM4 NAV3 FMN2 COL14A1 PABPC1L PAX6 PATJ EPB41

5.08e-0497317719Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlasalpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1

TNIK RBM33 WNK1 CEP350 THY1 SATB1 PRRC2C TANC1 SSH2 LY9

5.38e-0433617710GSM538413_500
CoexpressionAtlasdev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000

HIVEP1 KIF26B ZNF618 MUC16 GPATCH8 PHF21A CEP350 MRTFB SATB1 CLMN NFIL3 ATF7IP KIAA1217 COL14A1 LTBP1 SEMA6A MARCHF11

6.04e-0483117717gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

GTPBP4 THSD7A CRADD RBM33 TNRC6B R3HDM2 KIAA1614 TEX48 MRTFB FAM193A NFKB1 SETBP1 STRN4 FMN2 PAX6 KNL1 KPNB1

6.04e-0483117717Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STRN3 HIVEP1 TSC22D2 WNK1 FOXJ3 HNRNPL NFKB1 AFF1 LTBP1 UTY

4.76e-0918518110eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCellControl-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

THSD7A ACVRL1 PHF21A BICD1 MRTFB HECW2 KIAA1217 NAV3 LTBP1 SEMA6A

7.14e-0919318110e1d546165dcc2392f540162206852c4717d7306f
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9

KMT2E FOXJ3 FAM186B USF3 SMG7 ATF7IP CPLANE1 MGA SLFNL1

2.78e-08166181932d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCellCOVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients

COBLL1 TSC22D2 STK16 KMT2D TBC1D22A PRRC2C MYLIP NHS CTNNB1

4.61e-0817618192049767fd591045cfcf5b1071d80798e52843f27
ToppCellControl|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CRADD ACVRL1 BICD1 MRTFB KIAA1217 MYLIP SEMA6A TANC1 UTY

4.84e-081771819b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCellfacs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD164 WNK1 SEPTIN6 HNRNPL BPTF SATB1 PRRC2C MYLIP COL14A1

8.49e-0818918197ce71f9c81512ed38c804f025908746b4af3aab1
ToppCellrenal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 THSD7A COBLL1 SEMA6D KIAA1217 SETBP1 PATJ NFAT5 UTY

8.49e-081891819830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CFH MXRA5 KIF26B COL24A1 FNDC1 THY1 NAV3 NHS LTBP1

9.71e-08192181967e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell(08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition

ZNF618 ZC3H13 CILK1 KMT2E BPTF SBNO1 PRRC2C MUC4

9.98e-081381818817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCellCOVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations)

CFH COL24A1 DLC1 SETBP1 LRRTM4 NAV3 NHS COL14A1 LTBP1

1.02e-071931819e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

HIVEP1 RBM33 TNRC6B ZFC3H1 KMT2E WNK1 BPTF PRRC2C NFAT5

1.02e-071931819e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CFH MXRA5 KIF26B COL24A1 FNDC1 THY1 NAV3 NHS LTBP1

1.02e-0719318195de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCellFibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

CFH MXRA5 APOL1 FNDC1 DLC1 THY1 COL14A1 LTBP1 AMOTL2

1.26e-071981819e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCellFibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

CFH MXRA5 FNDC1 DLC1 THY1 COL14A1 C3 LTBP1 AMOTL2

1.32e-07199181913ff7409e200a0b46cdb7924d15ef33639693622
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

TANC2 ZC3H13 TNRC6B KMT2E CEP350 BPTF SBNO1 MAP4K5 PRRC2C

1.32e-071991819c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TNIK ZFC3H1 ZBTB37 BPTF PHC3 PRRC2C ATF7IP UTY EPB41

1.32e-071991819f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

RBM33 ZFC3H1 KMT2E HNRNPL CEP350 BPTF PRRC2C ATF7IP EPB41

1.37e-07200181912f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KIF26B COBLL1 DAZ1 BICD1 PLEKHG4B NPAP1 PATJ NFAT5

2.00e-07151181810da94037225a71844281ddcb395072250a78094
ToppCellfacs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH ZFC3H1 TSC22D2 WNK1 HNRNPL PRRC2C NAV3 SSH2

6.15e-0717518181ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCellControl-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KAT6A ACVRL1 MRTFB HECW2 KIAA1217 MYLIP SEMA6A PML

8.62e-071831818e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCellnormal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass

MXRA5 KIF26B COL24A1 FNDC1 ZNF469 THY1 COL14A1 LTBP1

8.98e-0718418180b336489c10e8c3c957795dd845454f03404382b
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

THSD7A COBLL1 BICD1 PLEKHG4B NPAP1 AFF1 SSH2 PATJ

9.36e-071851818d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCellpdx|World / Sample and Cell Type and Tumor Cluster (all cells)

CCDC200 KIF26B R3HDM2 GPATCH8 BICD1 BPTF R3HDM1 NFAT5

9.74e-071861818de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCellpdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

CCDC200 KIF26B R3HDM2 GPATCH8 BICD1 BPTF R3HDM1 NFAT5

9.74e-0718618180b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCellControl-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KAT6A HLX ACVRL1 MRTFB HECW2 KIAA1217 MYLIP SEMA6A

1.01e-061871818ea9d34bcd3bd1f36745846309ede349773de501a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TANC2 MXRA5 THSD7A COBLL1 BICD1 NPAP1 AFF1 NFAT5

1.14e-06190181811d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

HIVEP1 RBM33 TNRC6B ZFC3H1 KMT2E WNK1 BPTF NFAT5

1.24e-061921818916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

CFH MXRA5 THY1 SETBP1 NAV3 COL14A1 C3 LTBP1

1.24e-061921818e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ZFC3H1 TSC22D2 NFIL3 NFKB1 COL14A1 DENND5A AMOTL2 NFAT5

1.24e-0619218186bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COBLL1 KAT6A ACVRL1 MRTFB HECW2 KIAA1217 SEMA6A TANC1

1.29e-061931818a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellnucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MXRA5 KIF26B MARK1 FNDC1 THY1 CSPG4 LRRTM4 LTBP1

1.34e-0619418182d66091097e106c7bee22e5281f50724700bdf8d
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

THSD7A ACVRL1 BICD1 MRTFB DLC1 HECW2 KIAA1217 SEMA6A

1.34e-0619418180b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellfacs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD164 PHRF1 HNRNPL THY1 SATB1 PRRC2C ATF7IP UTY

1.34e-06194181866c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCellCOVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

TNIK KAT6A TNRC6B KMT2E LINS1 SATB1 PATJ EPB41

1.39e-0619518184bdedd924564a260841a9153604026b57487c83d
ToppCellfacs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC2 KAT6A CD164 GAL3ST4 SEMA6D PRRC2C MYLIP NAV3

1.39e-061951818a1478021a3ed0e779716393124ca2a7770c433b7
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IRF2BP2 SATB1 TULP4 PRRC2C FMN2 PAX6 MGA UTY

1.39e-0619518187796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD164 TSC22D2 WNK1 SEPTIN6 HNRNPL SMG7 PRRC2C CTNNB1

1.44e-061961818151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

CFH MXRA5 MARK1 FNDC1 DLC1 THY1 SEMA6D COL14A1

1.50e-0619718185afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

CFH MXRA5 MARK1 FNDC1 DLC1 THY1 SEMA6D COL14A1

1.50e-061971818b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

CFH MXRA5 KIF26B SETBP1 NAV3 NHS COL14A1 LTBP1

1.50e-061971818f1c8936986123a3151140c374fcd62d6705c530b
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

CFH MXRA5 MARK1 FNDC1 DLC1 THY1 SEMA6D COL14A1

1.50e-0619718181baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCellIPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

TNIK TANC2 CFH KIF26B BICD1 COL24A1 LTBP1 TANC1

1.50e-061971818f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

TANC2 EXPH5 ZC3H13 CEP350 TRIM33 BPTF SBNO1 MAP4K5

1.56e-06198181876d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCelldistal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CFH MXRA5 MUC16 CMYA5 TMEM200A FNDC1 THY1 C3

1.62e-0619918188dd5b411d2f1626830b77a1616cc3fb67dc59338
ToppCell10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CFH MXRA5 MARK1 FNDC1 DLC1 THY1 SEMA6D COL14A1

1.62e-0619918189b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

TANC2 ZC3H13 TNRC6B CEP350 BPTF SBNO1 MAP4K5 PRRC2C

1.62e-061991818fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellNS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CFH COBLL1 CMYA5 MRTFB KIAA1217 C3 NFAT5 TNS1

1.62e-06199181832bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCellILEUM-inflamed-(8)_Fibroblast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CFH MXRA5 FNDC1 THY1 COL14A1 C3 LTBP1 CAPN5

1.62e-061991818cb3c04b91c8e8080137823b11c76ca0a2adda52d
ToppCell10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CFH MXRA5 MARK1 FNDC1 DLC1 THY1 SEMA6D COL14A1

1.62e-061991818251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CFH SATB2 MXRA5 DLC1 THY1 SEMA6D NAV3 COL14A1

1.62e-0619918186200618e029063486719479c41eaf31798bd13cf
ToppCell10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CFH MXRA5 MARK1 FNDC1 DLC1 THY1 SEMA6D COL14A1

1.62e-061991818117f4f43b6c06dda553799b1063e827bce697370
ToppCell(5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

CFH MXRA5 THY1 NAV3 COL14A1 C3 LTBP1 CAPN5

1.68e-06200181875e5ecb05e965e24d569aa2ef5cdf740b1528c06
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9

GTPBP4 CNKSR1 CCDC168 TRIM33 MAP4K5 ATF7IP EPB41

2.63e-061491817768877bade04ca0321593b8470b5011ad8270431
ToppCellNS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

TNIK CACNA1F THSD7A ZNF618 PLEKHG4B DLC1 NLGN4X

4.22e-061601817c61869d9dbba250270e59366e15af204e5b4395d
ToppCellnormal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass

MXRA5 KIF26B PLEKHG4B COL24A1 FNDC1 ZNF469 KIAA1217

4.96e-0616418179b4a6007abae992db871d9f6f731d5af724de30d
ToppCelldroplet-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH CD14 NFIL3 NAV3 C3 LTBR TNFRSF1B

5.37e-061661817e841e62cb20235d6233f78f4155fb8c0ffb1ef1b
ToppCelldroplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH CD14 NFIL3 NAV3 C3 LTBR TNFRSF1B

5.37e-061661817f751cbd01d4978ded7755874ab60504f6291afd7
ToppCelldroplet-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH CD14 NFIL3 NAV3 C3 LTBR TNFRSF1B

5.37e-0616618173ca3ddb663644f0e7f70f9b75833bb54cd9191d3
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH MINK1 CD14 SSH2 AMOTL2 TNFRSF1B CCDC158

5.81e-061681817e979a4fbeb9f21048b47d69e6da75c57650697f2
ToppCellControl-T/NK_proliferative|World / Disease group and Cell class

BICD1 AURKA HECW2 TANC1 LTBR KNL1 PHF13

6.04e-061691817fca735cbb55fce4d32dc6632a39acea1d16b87ab
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CNKSR1 MIB2 SEPTIN6 BCLAF3 PLEKHG4B TANC1 TNFRSF1B

6.04e-061691817665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CNKSR1 MIB2 SEPTIN6 BCLAF3 PLEKHG4B TANC1 TNFRSF1B

6.04e-0616918176614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MXRA5 COBLL1 CMYA5 BICD1 NPAP1 AFF1 NFAT5

6.28e-061701817928e42c51a7079c506f21c669c4e4c1a0df84d77
ToppCellControl-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations)

HAP1 MARK1 DLC1 SEMA6D CSPG4 LRRTM4 TNS1

6.53e-061711817080003f698f867935c2bfc55d241d3650f45a0ab
ToppCellfacs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH ZFC3H1 TSC22D2 WNK1 HNRNPL PRRC2C SSH2

7.05e-061731817869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFH MARK1 MUC16 APOL1 C3 PAX6 MUC4

7.05e-061731817176b956e71d98e8275d698b39437fc326e5fe449
ToppCellfacs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH ZFC3H1 TSC22D2 WNK1 HNRNPL PRRC2C SSH2

7.05e-0617318170672bd8a4a9d18af343d01f09253fb3388896c10
ToppCellfacs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH ZFC3H1 TSC22D2 WNK1 HNRNPL PRRC2C SSH2

7.05e-061731817870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH CMYA5 ESCO1 CEP350 PRRC2C ATF7IP COL14A1

7.88e-061761817749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellChildren_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

MARK1 DLC1 SEMA6D CLMN CSPG4 LRRTM4 TNS1

8.49e-061781817185b44700f06ec58b3c09c80520502166c965fd6
ToppCellwk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

CFH CCDC110 IQCN KIAA1614 BCLAF3 FNDC1 CSPG4

8.49e-061781817a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TANC2 MUC16 CMYA5 KIAA1217 TANC1 PATJ MUC4

8.80e-0617918176e965e424eebef50f0202cff75f458be395cfca1
ToppCellCOVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type

DLC1 CLMN SETBP1 CSPG4 KCNMA1 NHS COL14A1

8.80e-061791817a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CNKSR1 COBLL1 CCDC110 IQCN QRICH2 SETBP1 KCNMA1

9.13e-0618018178e96f8646c002768b272359af485dc0ab57e0ccd
ToppCellfacs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH CD164 HNRNPL SMG7 SATB1 PRRC2C SSH2

9.13e-06180181787fb1fdbc49c808bb5f6fe9fb747057b45fa78d0
ToppCellChildren_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

CFH MARK1 COL24A1 SEMA6D LRRTM4 NHS LTBP1

9.13e-06180181701f2e5d96016823482f89ba503d007d4bd88eeac
ToppCellfacs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH CD164 HNRNPL SMG7 SATB1 PRRC2C SSH2

9.13e-061801817c0c3144011856d005aebd5cdc79f89fee32083a8
ToppCellnucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TNRC6B BICD1 TBC1D22A ATF7IP SETBP1 SSH2 LY9

9.46e-0618118178d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CFH ANKRD35 FNDC1 THY1 NAV3 COL14A1 C3

9.46e-061811817e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc
ToppCellmetastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass

MXRA5 FNDC1 NLGN4X THY1 LTBP1 PAX6 MARCHF11

9.46e-061811817bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TANC2 COBLL1 IQCN NLGN4X SEMA6D KCNMA1 COL14A1

9.81e-061821817a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CPEB2 EXPH5 COBLL1 TSC22D2 WNK1 SEMA6D CLMN

1.02e-0518318172f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HAP1 MARK1 TMEM200A SEMA6D CSPG4 LRRTM4 TANC1

1.09e-051851817a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor

COBLL1 SLC5A9 SEMA6D TANC1 AMOTL2 PATJ CPLANE1

1.09e-05185181732b4e68e551d435a732f253f6ad83408c759a642
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

TNIK ZC3H13 ZKSCAN8 CEP350 TRIM33 PHC3 NFAT5

1.13e-05186181703db813598b67b1e08f759758a1c2023396921fa
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

CFH MARK1 COL24A1 SETBP1 LRRTM4 NAV3 LTBP1

1.17e-051871817bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TANC2 STRN3 SATB2 THSD7A NHS PATJ TNS1

1.17e-051871817c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TANC2 NLGN4Y COBLL1 SEMA6D KCNMA1 COL14A1 PATJ

1.17e-05187181777886f99c229610abd28c4c370d2c7d1536c9782
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HAP1 MARK1 TMEM200A SEMA6D CSPG4 LRRTM4 TANC1

1.17e-051871817a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TANC2 THSD7A COBLL1 BICD1 NPAP1 AFF1 SSH2

1.17e-051871817e3095455d2f255854f339f6b05fa87852af0700f
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9

MXRA5 ZC3H13 FNDC1 ZNF469 THY1 LTBP1 AMOTL2

1.21e-05188181714bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TANC2 THSD7A COBLL1 BICD1 NPAP1 AFF1 NFAT5

1.21e-051881817e30a4ddac0da8cdcf621d98e28e3895cd9307e7a
ToppCellhuman_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

EXPH5 BICD1 KIAA1217 KCNMA1 NHS SEMA6A TANC1

1.21e-051881817b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH IRF2BP2 KAT6A CD164 HNRNPL MYLIP SSH2

1.25e-0518918176dd4ec5ce4beb856f0d2d1654e3c4676d1d63736
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH IRF2BP2 KAT6A CD164 HNRNPL MYLIP SSH2

1.25e-051891817875df61ee48baa5142ba4d2427bdec1c53e5a828
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CPEB2 MARK1 EXPH5 COBLL1 TSC22D2 WNK1 SEMA6D

1.25e-051891817977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH IRF2BP2 KAT6A CD164 HNRNPL MYLIP SSH2

1.25e-0518918173ae479ec7e00c57127cbe51a398329b10ca9848c
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass

SATB2 COBLL1 ZBTB37 CSPG4 COL14A1 R3HDM1 TNS1

1.25e-051891817f4865b7db16de15120504147a8016ac522ad242a
ToppCellfacs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH IRF2BP2 KAT6A CD164 HNRNPL MYLIP SSH2

1.25e-05189181797ef5215d841ff366a3e3682cd9bd04100cbfde0
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MXRA5 COBLL1 CMYA5 BICD1 NPAP1 AFF1 NFAT5

1.30e-051901817078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
DrugMethotrexate [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A

GPR137 CNKSR1 HLX GAL3ST4 WNK1 AURKA TULP4 NFIL3 KCNMA1 TNS1 PML

3.35e-07190179116318_DN
DrugPhenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A

GPR137 TANC2 CRYBG2 IRF2BP1 MARK1 ARHGEF16 TBC1D22A SETBP1 MYLIP R3HDM1 UTY

4.13e-07194179113725_DN
Drug3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A

STRN3 IRF2BP1 EXPH5 MINK1 LINS1 PHC3 SMG7 SIGLEC6 LY9 NFAT5 TNS1

4.81e-07197179114764_DN
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

TANC2 HIVEP1 COBLL1 FOXJ3 PHF21A BICD1 TRIM33 MRTFB TULP4 ATF7IP

1.24e-06174179107530_DN
DrugMepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A

TNIK TANC2 STRN3 KAT6A WNK1 BICD1 CEP350 SBNO1 R3HDM1 NFAT5

2.62e-06189179104304_DN
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A

TANC2 STRN3 EXPH5 KAT6A WNK1 BICD1 CEP350 SMG7 KCNMA1 NFAT5

2.88e-06191179104279_DN
DrugPhenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A

TANC2 STRN3 KAT6A WNK1 TRIM33 SMG7 PRRC2C LTBP1 ZNF160 NFAT5

2.88e-06191179104283_DN
DrugLetrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A

GPR137 IRF2BP1 WNK1 BICD1 PHF1 SMG7 TBC1D22A AFF1 LY9 PML

3.17e-06193179104240_DN
DrugAllantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A

CRYBG2 HAP1 MINK1 WNK1 MEF2D PHF1 DLC1 TBC1D22A R3HDM1 PML

3.63e-06196179105052_UP
DrugIocetamic acid [16034-77-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A

IRF2BP1 TSC22D2 MEF2D SEMA6D BRS3 KCNMA1 AFF1 CAPN5 PAX6 PML

3.80e-06197179103361_UP
Drug5707885; Down 200; 50uM; MCF7; HT_HG-U133A

IRF2BP1 SEPTIN6 BICD1 SATB1 BRS3 TBC1D22A KCNMA1 PAX6 LY9 PML

3.80e-06197179106385_DN
DrugAmitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A

GTPBP4 STRN3 CNKSR1 MINK1 GPATCH8 BICD1 CEP350 PHC3 CNOT9 NFAT5

3.98e-06198179101701_DN
DrugOrlistat; Down 200; 10uM; PC3; HT_HG-U133A

TANC2 STRN3 TSC22D2 WNK1 FOXJ3 TBC1D22A C3 CPLANE1 TNS1 PML

4.16e-06199179106420_DN
DrugLanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A

KAT6A TSC22D2 FOXJ3 CEP350 LINS1 ATF7IP MYLIP AMOTL2 NFAT5

6.25e-0616417993852_UP
DrugAdiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A

GTPBP4 STRN3 IRF2BP1 EXPH5 WNK1 HNRNPL CEP350 SMG7 NFAT5

1.51e-0518317991709_DN
DrugSDZ 880.431

CD14 C3 TNFRSF1B

1.63e-0571793CID000127963
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A

EXPH5 WNK1 HNRNPL BICD1 CEP350 TRIM66 PRRC2C LTBP1 NFAT5

1.65e-0518517991673_DN
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A

TANC2 STRN3 EXPH5 WNK1 CEP350 SMG7 MAP4K5 KCNMA1 NFAT5

1.95e-0518917994271_DN
DrugPempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A

STRN3 KAT6A WNK1 CEP350 SMG7 SBNO1 R3HDM1 ZNF160 NFAT5

2.03e-0519017994307_DN
DrugSulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A

GPR137 GTPBP4 CILK1 WNK1 BICD1 TRIM33 PHC3 ZNF160 NFAT5

2.03e-0519017993373_DN
DrugMethapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A

EXPH5 KAT6A WNK1 CEP350 SMG7 TBC1D22A C3 LTBP1 PML

2.12e-0519117996644_DN
DrugAld1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A

CRYBG2 IRF2BP1 MINK1 TOM1 HLX TNRC6B PHC3 TNS1 PML

2.12e-0519117997547_UP
DrugAG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A

TANC2 IRF2BP1 COBLL1 WNK1 MEF2D SMG7 CLMN LTBP1 PML

2.21e-0519217996435_DN
Drug5707885; Down 200; 50uM; PC3; HT_HG-U133A

TNIK MEF2D PHC3 SMG7 CLMN NAV3 UTY PML KPNB1

2.21e-0519217996438_DN
DrugMetanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HT_HG-U133A

IRF2BP1 COBLL1 HLX TSC22D2 SMG7 NAV3 PATJ CPLANE1 TNS1

2.30e-0519317996734_DN
DrugSpiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A

STRN3 MINK1 KAT6A WNK1 HNRNPL BICD1 SMG7 PATJ NFAT5

2.40e-0519417994319_DN
DrugCyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A

GTPBP4 TNRC6B WNK1 ARHGEF16 PHF1 TRIM33 PHC3 SETBP1 NFAT5

2.40e-0519417994470_DN
DrugDiethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A

GPR137 CRYBG2 GAL3ST4 NLGN4X THY1 SEMA6D SMG7 SIGLEC6 COL14A1

2.40e-0519417993812_UP
DrugCephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A

GPR137 IRF2BP1 COBLL1 MINK1 PHF1 TRIM33 TBC1D22A AFF1 PML

2.40e-0519417994242_DN
DrugLynestrenol [52-76-6]; Up 200; 14uM; PC3; HT_HG-U133A

HAP1 KAT6A ARHGEF16 MEF2D STK16 SMG7 CLMN LY9 CPLANE1

2.60e-0519617996756_UP
DrugEpivincamine [6835-99-0]; Down 200; 11.2uM; PC3; HT_HG-U133A

GPR137 IRF2BP1 GAL3ST4 MEF2D BICD1 TBC1D22A ELF4 TNS1 PML

2.60e-0519617994500_DN
DrugPromazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A

STRN3 CNKSR1 WNK1 BICD1 TRIM66 PHC3 SEMA6D TBC1D22A PATJ

2.60e-0519617996028_DN
DrugLY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A

GTPBP4 SATB2 CRADD WNK1 BICD1 SMG7 TBC1D22A MAP4K5 LTBP1

2.71e-0519717991641_DN
Drug(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; PC3; HT_HG-U133A

GTPBP4 IRF2BP1 MEF2D BICD1 STK16 SMG7 TNS1 UTY PML

2.71e-0519717995108_DN
DrugMianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

TNIK MINK1 KAT6A ARHGEF16 BICD1 PHF1 TRIM66 LINS1 FAM222B

2.82e-0519817995786_DN
DrugDiphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A

CFH HAP1 COBLL1 CILK1 MEF2D STK16 TBC1D22A TNS1 PML

2.82e-0519817993743_UP
DrugDextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; PC3; HT_HG-U133A

GTPBP4 CRYBG2 TAF1C TOM1 WNK1 BICD1 SEMA6A CPLANE1 TNS1

2.82e-0519817996300_UP
DrugGlimepiride [93479-97-1]; Up 200; 8.2uM; HL60; HT_HG-U133A

GPR137 IRF2BP1 COBLL1 GAL3ST4 MRTFB NLGN4X AFF1 LTBP1 PML

2.82e-0519817992154_UP
DrugHydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A

TANC2 STRN3 TSC22D2 WNK1 SEPTIN6 KCNMA1 R3HDM1 NFAT5 PML

2.82e-0519817994282_DN
DrugNaproxen [22204-53-1]; Up 200; 17.4uM; PC3; HT_HG-U133A

GPR137 TANC2 CRYBG2 REM1 MINK1 STK16 LINS1 PATJ PML

2.82e-0519817996358_UP
DrugNialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A

MEF2D BICD1 PHC3 TBC1D22A SIGLEC6 KCNMA1 R3HDM1 LY9 PML

2.82e-0519817994525_UP
DrugCatechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; HL60; HT_HG-U133A

THSD7A TAF1C COBLL1 TSC22D2 PHC3 DLC1 TBC1D22A CAPN5 PML

2.82e-0519817993012_DN
DrugThiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A

GTPBP4 HIVEP1 HLX CILK1 BICD1 TRIM33 SMG7 FAM222B NFAT5

2.93e-0519917995095_DN
DrugGabapentin [60142-96-3]; Down 200; 23.4uM; PC3; HT_HG-U133A

GPR137 KAT6A HLX TRIM33 BPTF MAP4K5 FAM222B NAV3 UTY

2.93e-0519917995875_DN
DrugLevopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A

REM1 TAF1C COBLL1 MINK1 WNK1 MEF2D BICD1 SEMA6D COL14A1

2.93e-0519917993543_DN
DrugKarakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A

GPR137 CRYBG2 HAP1 COBLL1 TSC22D2 THY1 SIGLEC6 C3 UTY

2.93e-0519917993638_DN
DrugPF-00539758-00 [351321-34-1]; Down 200; 10uM; MCF7; HT_HG-U133A

GPR137 IRF2BP1 MARK1 TSC22D2 MEF2D PHF1 DLC1 CD14 LY9

2.93e-0519917996416_DN
DrugFlurbiprofen [5104-49-4]; Up 200; 16.4uM; MCF7; HT_HG-U133A

GPR137 TNIK CNKSR1 MINK1 TSC22D2 TBC1D22A KCNMA1 C3 PML

2.93e-0519917995269_UP
DrugPropylthiouracil [51-52-5]; Down 200; 23.4uM; PC3; HT_HG-U133A

MINK1 ARHGEF16 TRIM33 DLC1 SMG7 TBC1D22A R3HDM1 TNS1 UTY

3.05e-0520017994076_DN
DrugAntipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; PC3; HT_HG-U133A

TAF1C MINK1 WNK1 PHF1 PHC3 MYLIP KCNMA1 PATJ PML

3.05e-0520017994095_DN
DrugHelveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A

KAT6A FOXJ3 CEP350 LINS1 ATF7IP MYLIP AMOTL2 NFAT5

5.02e-0516517983851_UP
DrugLanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A

HIVEP1 THSD7A KAT6A TSC22D2 PHF1 LINS1 ATF7IP STRN4

5.94e-0516917982193_UP
DrugNiclosamide [50-65-7]; Up 200; 12.2uM; HL60; HG-U133A

HIVEP1 TOM1 PHF1 NFIL3 NFKB1 AFF1 C3 NFAT5

6.72e-0517217981998_UP
DrugMelphalan

ZNF618 CCDC110 TNRC6B TMEM200A PHF21A MRTFB SEMA6D HECW2 FMN2 NHS

6.96e-0527617910ctd:D008558
DrugICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA

GPATCH8 CEP350 TRIM33 BPTF DLC1 PRRC2C MYLIP ZNF160

8.22e-051771798985_DN
DrugStrophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A

TSC22D2 DLC1 ATF7IP SEMA6A AMOTL2 PATJ NFAT5 PML

8.89e-0517917982656_UP
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A

STRN3 KAT6A FOXJ3 CEP350 AURKA TRIM33 MRTFB CDCA4

9.24e-0518017984541_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

STRN3 QRICH1 PHF21A CEP350 AURKA TRIM33 MRTFB MGA

9.98e-0518217983887_DN
DrugGW8510; Down 200; 10uM; PC3; HT_HG-U133A

TSC22D2 AURKA MRTFB FAM193A ATF7IP AMOTL2 MGA CDCA4

9.98e-0518217987085_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

TSC22D2 CEP350 AURKA TRIM33 BPTF MRTFB ATF7IP MGA

1.08e-0418417982321_DN
DrugParthenolide [20554-84-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A

GPR137 TNIK IRF2BP1 WNK1 STK16 AMOTL2 R3HDM1 NFAT5

1.08e-0418417985530_UP
DrugGW8510; Down 200; 10uM; MCF7; HT_HG-U133A

AURKA TRIM33 MRTFB FAM193A ATF7IP AMOTL2 MGA CDCA4

1.20e-0418717987080_DN
DrugResveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A

GTPBP4 COBLL1 MINK1 AURKA LINS1 PHC3 NFAT5 UTY

1.30e-0418917985084_DN
DrugEthisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A

GPR137 TAF1C MINK1 BICD1 THY1 SIGLEC6 PATJ UTY

1.34e-0419017984340_DN
DrugChelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A

STRN3 REM1 IRF2BP1 KAT6A CEP350 KCNMA1 AFF1 PML

1.39e-0419117986236_UP
Drug15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A

TANC2 HIVEP1 COBLL1 TSC22D2 BICD1 DLC1 ELF4 KPNB1

1.44e-0419217986990_DN
DrugEtofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A

GPR137 COBLL1 SETBP1 MYLIP KCNMA1 C3 PATJ PML

1.44e-0419217984108_UP
DrugRilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A

REM1 TAF1C WNK1 SEPTIN6 SMG7 LY9 PML KPNB1

1.44e-0419217986512_UP
DrugDNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A

IRF2BP1 MINK1 HLX PHC3 DLC1 TBC1D22A PATJ PML

1.44e-0419217987548_UP
DrugPF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A

IRF2BP1 HAP1 COBLL1 LRRTM4 KCNMA1 SEMA6A TNS1 UTY

1.44e-0419217985967_UP
DrugSulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A

COBLL1 KAT6A TNRC6B STK16 CEP350 COL14A1 NFAT5 PML

1.50e-0419317984690_DN
DrugCarbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A

TAF1C COBLL1 MINK1 KAT6A DLC1 KCNMA1 NFAT5 PML

1.50e-0419317983250_UP
DrugEthoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A

TANC2 STRN3 TAF1C WNK1 SMG7 C3 NFAT5 PML

1.50e-0419317984321_DN
DrugPhenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A

GPR137 TANC2 GAL3ST4 PHF1 FAM222B MYLIP NAV3 UTY

1.50e-0419317985758_DN
DrugLomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A

STRN3 MINK1 KAT6A WNK1 PHC3 SMG7 SIGLEC6 R3HDM1

1.55e-0419417984281_DN
Drugrapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A

CRYBG2 REM1 TOM1 PHC3 NAV3 R3HDM1 LY9 TNS1

1.55e-0419417985932_DN
DrugPiperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A

STRN3 KAT6A WNK1 BICD1 SMG7 MAP4K5 FAM222B NFAT5

1.55e-0419417984320_DN
DrugMetaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A

CNKSR1 IRF2BP1 MINK1 TBC1D22A NAV3 ELF4 TNS1 PML

1.55e-0419417984248_DN
DrugNystatine [1400-61-9]; Up 200; 4.4uM; PC3; HT_HG-U133A

GPR137 REM1 MINK1 MUC16 WNK1 COL14A1 LY9 PATJ

1.55e-0419417984223_UP
DrugAztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A

IRF2BP1 MINK1 WNK1 FOXJ3 BICD1 STK16 ZNF160 NFAT5

1.55e-0419417982118_DN
DrugBeta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A

ALX3 ZC3H13 GAL3ST4 MEF2D DLC1 NLGN4X SIGLEC6 PML

1.61e-0419517983890_UP
Drugpioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A

GPR137 IRF2BP1 MEF2D DLC1 CLMN NAV3 R3HDM1 CPLANE1

1.61e-0419517985977_DN
Drug3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A

TANC2 STRN3 IRF2BP1 MARK1 COBLL1 KAT6A ARHGEF16 STK16

1.61e-0419517984298_UP
DrugBambuterol hydrochloride [81732-46-9]; Down 200; 10uM; HL60; HG-U133A

CD164 WNK1 SEPTIN6 NDUFAF4 SATB1 FAM222B PML KPNB1

1.61e-0419517981582_DN
DrugAzlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A

EXPH5 TAF1C TNRC6B MEF2D PHC3 MRTFB AFF1 PML

1.61e-0419517982727_DN
Drugoxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA

GPR137 GTPBP4 STRN3 IRF2BP1 MINK1 TBC1D22A NFAT5 KPNB1

1.61e-041951798863_DN
DrugChicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A

REM1 IRF2BP1 MINK1 HLX PHC3 TBC1D22A SETBP1 NAV3

1.61e-0419517986626_DN
DrugPropylthiouracil [51-52-5]; Down 200; 23.4uM; HL60; HT_HG-U133A

EXPH5 TAF1C WNK1 SMG7 SBNO1 MAP4K5 SIGLEC6 NFAT5

1.66e-0419617982476_DN
DrugICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A

GPR137 CNKSR1 IRF2BP1 MINK1 PHF1 TBC1D22A SIGLEC6 CPLANE1

1.66e-0419617985926_UP
DrugEserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; PC3; HT_HG-U133A

TANC2 STRN3 CRYBG2 MEF2D PHF1 TRIM66 NAV3 PML

1.66e-0419617985749_DN
Drugprochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A

COBLL1 BICD1 PHF1 THY1 SEMA6D CSPG4 COL14A1 PML

1.66e-0419617986174_UP
DrugGossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A

TNIK GTPBP4 TNRC6B ARHGEF16 PHF1 KCNMA1 TNS1 PML

1.66e-0419617984296_DN
DrugGramine [87-52-5]; Up 200; 23uM; PC3; HT_HG-U133A

TNIK GAL3ST4 WNK1 TRIM33 TRIM66 DLC1 R3HDM1 PATJ

1.66e-0419617983999_UP
DrugDemeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A

GTPBP4 STRN3 MINK1 WNK1 STK16 SMG7 MAP4K5 TNS1

1.66e-0419617984728_DN
DrugAlthiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A

IRF2BP1 TAF1C MEF2D SEPTIN6 R3HDM1 PATJ TNS1 PML

1.66e-0419617984491_DN
DrugOrphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A

GPR137 IRF2BP1 EXPH5 MINK1 KAT6A TNRC6B BICD1 TBC1D22A

1.66e-0419617984359_DN
DrugLithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A

GPR137 CRYBG2 IRF2BP1 TNRC6B SIGLEC6 C3 PATJ PML

1.66e-0419617983816_DN
DrugL(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; HL60; HT_HG-U133A

EXPH5 MINK1 MEF2D TRIM33 MRTFB DLC1 SMG7 TBC1D22A

1.66e-0419617983118_DN
DrugKynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A

GPR137 IRF2BP1 COBLL1 KAT6A WNK1 MEF2D DLC1 SMG7

1.72e-0419717985276_UP
DrugPivampicillin [33817-20-8]; Up 200; 8.6uM; PC3; HT_HG-U133A

ALX3 HAP1 MARK1 SIGLEC6 COL14A1 SEMA6A TNS1 PML

1.72e-0419717985046_UP
Diseasecortical surface area measurement

ALX3 TNIK TANC2 STRN3 SATB2 KIF26B ZC3H13 TNRC6B GAL3ST4 TSC22D2 KIAA1614 GATAD2B PHF21A COL24A1 ZNF469 TBC1D22A PRRC2C NFKB1 NAV3 AFF1 SEMA6A SSH2 TNS1

6.82e-06134517823EFO_0010736
Diseaseneuroimaging measurement, brain volume measurement

TNIK STRN3 CRADD KIF26B ESCO1 GATAD2B BICD1 BPTF NAV3 NFAT5

1.02e-0528617810EFO_0004346, EFO_0006930
Diseaseaspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement

HIVEP1 COBLL1 MIB2 IQCN TSC22D2 TRIM66 BPTF SETBP1 SSH2 PATJ NFAT5

1.44e-0536417811EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Diseasewaist-hip ratio

CFH CRADD COBLL1 HLX TNRC6B IQCN TSC22D2 WNK1 TRIM33 TRIM66 BPTF COL24A1 DLC1 TBC1D22A SETBP1 NAV3 COL14A1 PATJ NFAT5 KNL1 PML

1.73e-05122617821EFO_0004343
Diseasebody weight

GPR137 HIVEP1 CRADD TNRC6B TSC22D2 SPATA31C1 PHF21A BICD1 TRIM66 BPTF USF3 SEMA6D TULP4 MAP4K5 NFIL3 KIAA1217 SETBP1 LTBP1 PATJ MGA KPNB1

2.61e-05126117821EFO_0004338
Diseasechronotype measurement

TANC2 HIVEP1 ZNF618 TNRC6B R3HDM2 ZBTB37 TRIM33 KMT2D FAM193A SEMA6D HECW2 LRRTM4 NAV3 PABPC1L SEMA6A R3HDM1 PATJ

2.69e-0588217817EFO_0008328
Diseasecomplement C3B measurement

CFH C3

3.62e-0521782EFO_0020275
Diseasetriglycerides in very small VLDL measurement

COBLL1 R3HDM2 BPTF MAP4K5 AFF1

5.79e-05681785EFO_0022144
Diseasetotal cholesterol measurement, very low density lipoprotein cholesterol measurement

IRF2BP1 COBLL1 R3HDM2 BPTF MAP4K5 MYLIP AFF1 KPNB1

6.87e-052241788EFO_0004574, EFO_0008317
DiseaseKabuki syndrome (implicated_via_orthology)

KMT2D UTY

1.08e-0431782DOID:0060473 (implicated_via_orthology)
Diseasecomplement C3D fragment measurement

CFH C3

1.08e-0431782EFO_0020277
Diseasecomplement C3 measurement

CFH C3

1.08e-0431782EFO_0004983
Diseasetumor necrosis factor receptor superfamily member 1B measurement

MAP4K5 TNFRSF1B

1.08e-0431782EFO_0010624
Diseaseserine/threonine-protein kinase receptor R3 measurement

CFH ACVRL1

1.08e-0431782EFO_0020733
Diseaseneurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (implicated_via_orthology)

IRF2BP2 IRF2BP1

1.08e-0431782DOID:0081327 (implicated_via_orthology)
Diseasecortical thickness

TNIK IRF2BP2 STRN3 SATB2 TNRC6B TSC22D2 KIAA1614 GATAD2B ZNF469 DLC1 SMG7 TBC1D22A NFKB1 NAV3 FMN2 AFF1 SSH2 TNS1

1.46e-04111317818EFO_0004840
DiseaseHMG CoA reductase inhibitor use measurement

TSC22D2 ACVRL1 MAP4K5 FAM222B MYLIP PHF13 KPNB1

1.57e-041891787EFO_0009932
Diseasebrain connectivity measurement

TNIK STRN3 SATB2 KIF26B QRICH1 TSC22D2 KIAA1614 NAV3 AFF1 SSH2

1.69e-0440017810EFO_0005210
Diseasecystatin C measurement

GTPBP4 ZKSCAN8 R3HDM2 ARHGEF16 MAP4K5 KIAA1217 CSPG4 TANC1 NFAT5 CCDC158

1.76e-0440217810EFO_0004617
Diseasebody fat percentage

HIVEP1 COBLL1 MIB2 IQCN TSC22D2 TRIM66 BPTF SETBP1 SSH2 PATJ NFAT5

1.98e-0448817811EFO_0007800
DiseaseIGF-1 measurement

CRADD MARK1 HLX R3HDM2 PHF1 TRIM66 PHC3 SBNO1 MAP4K5 EME2 CRAMP1

1.98e-0448817811EFO_0004627
Diseaseautosomal recessive polycystic kidney disease (is_marker_for)

CD14 C3

2.15e-0441782DOID:0110861 (is_marker_for)
DiseaseOsteoarthritis, Knee

SBNO1 LTBP1

2.15e-0441782C0409959
Diseaseleucine-rich repeat transmembrane neuronal protein 4 measurement

CFH LRRTM4

2.15e-0441782EFO_0802697
Diseasesemaphorin-6A measurement

CFH SEMA6A

2.15e-0441782EFO_0020721
Diseaseneuroligin-4, x-linked measurement

CFH NLGN4X

2.15e-0441782EFO_0020601
DiseaseNeurodevelopmental Disorders

TANC2 TNRC6B KMT2E SETBP1 CTNNB1

2.56e-04931785C1535926
Diseasetriglyceride measurement, phospholipid measurement

COBLL1 R3HDM2 TSC22D2 BPTF MAP4K5 AFF1

2.67e-041461786EFO_0004530, EFO_0004639
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

CRADD CILK1 KCNMA1 NAV3 FMN2 MUC4

2.88e-041481786C0279702
Diseasefree cholesterol measurement, very low density lipoprotein cholesterol measurement

COBLL1 R3HDM2 BPTF MAP4K5 MYLIP AFF1 KPNB1

3.44e-042151787EFO_0008317, EFO_0008591
Diseasesingle Ig IL-1-related receptor measurement

CFH ITIH1

3.58e-0451782EFO_0802072
Diseasetriglycerides in LDL measurement

COBLL1 BPTF MAP4K5 AFF1

3.68e-04561784EFO_0022320
Diseasetransient cerebral ischemia (biomarker_via_orthology)

ACVRL1 WNK1 NFKB1 C3 LTBP1 PAX6

3.94e-041571786DOID:224 (biomarker_via_orthology)
Diseasecognitive function measurement

TANC2 IRF2BP2 HIVEP1 THSD7A ZNF618 TSC22D2 KMT2E FAM186B GATAD2B KMT2D FAM193A SEMA6D TULP4 TBC1D22A PRRC2C ATF7IP KIAA1217 SETBP1 LTBP1 CTNNB1

4.34e-04143417820EFO_0008354
Diseasecholesteryl ester measurement, very low density lipoprotein cholesterol measurement

IRF2BP1 COBLL1 R3HDM2 MAP4K5 MYLIP AFF1 KPNB1

4.52e-042251787EFO_0008317, EFO_0010351
Diseaseapolipoprotein A 1 measurement, apolipoprotein B measurement

CFH COBLL1 R3HDM2 MYLIP KPNB1

4.88e-041071785EFO_0004614, EFO_0004615
Diseasetriglycerides in small VLDL measurement

COBLL1 BPTF MAP4K5 AFF1

5.11e-04611784EFO_0022145
Diseasev-set and transmembrane domain-containing protein 4 measurement

CFH C3

5.34e-0461782EFO_0803247
Disease2-myristoyl-GPC (14:0) measurement

ESCO1 MAP4K5

5.34e-0461782EFO_0800242
Disease1-myristoyl-GPC (14:0) measurement

ESCO1 MAP4K5

5.34e-0461782EFO_0800221
Diseaselow density lipoprotein cholesterol measurement, body mass index

COBLL1 MAP4K5

5.34e-0461782EFO_0004340, EFO_0004611
Diseasetriglycerides in small HDL measurement

COBLL1 BPTF MAP4K5 AFF1

5.44e-04621784EFO_0022158
Diseasephospholipids in large VLDL measurement

COBLL1 BPTF MAP4K5 AFF1

5.44e-04621784EFO_0022169
Diseasetriglycerides in medium LDL measurement

COBLL1 BPTF MAP4K5 AFF1

5.44e-04621784EFO_0022322
Diseasetriglycerides to total lipids in very large HDL percentage

COBLL1 BPTF MAP4K5 AFF1

5.44e-04621784EFO_0022339
Diseasebody surface area

SATB2 HIVEP1 CRADD WNK1 SPATA31C1 TRIM66 COL24A1 DLC1 MAP4K5 NFIL3 LTBP1 PATJ

5.63e-0464317812EFO_0022196
DiseaseColorectal cancer

AURKA DLC1 CTNNB1

5.68e-04271783cv:C0346629
DiseaseNeoplasm of the large intestine

AURKA DLC1 CTNNB1

5.68e-04271783cv:C0009404
DiseaseCOLORECTAL CANCER

AURKA DLC1 CTNNB1

5.68e-04271783114500
Diseasetriglyceride measurement, intermediate density lipoprotein measurement

COBLL1 R3HDM2 BPTF MAP4K5 AFF1

5.78e-041111785EFO_0004530, EFO_0008595
Diseasediverticular disease

KIF26B HLX TNRC6B DLC1 KIAA1217 LTBP1 TNS1

6.00e-042361787EFO_0009959
Diseasetriglycerides in small LDL measurement

COBLL1 BPTF MAP4K5 AFF1

6.51e-04651784EFO_0022323
Diseasevisceral adipose tissue measurement

MIB2 IQCN WNK1 PHF1 TRIM66 BPTF NFIL3 COL14A1 PATJ NFAT5

7.20e-0448117810EFO_0004765
Diseaseregulator of G-protein signaling 8 measurement

CFH C3

7.45e-0471782EFO_0801997
Diseasepsoriasis (implicated_via_orthology)

LTBR TNFRSF1B

7.45e-0471782DOID:8893 (implicated_via_orthology)
Diseasepulse pressure measurement

CFH MXRA5 CRADD RBM33 ZNF618 COBLL1 TNRC6B TSC22D2 GPATCH8 FAM186B ITIH1 TRIM66 FNDC1 FAM193A DLC1 KIAA1217 LTBP1 NFAT5 PHF13

7.85e-04139217819EFO_0005763
Diseaseneuroimaging measurement

TNIK STRN3 CRADD KIF26B TNRC6B TSC22D2 GATAD2B BICD1 COL24A1 ZNF469 SBNO1 PRRC2C NAV3 AFF1 SSH2 TNS1

7.95e-04106917816EFO_0004346
Diseasered blood cell density measurement

IRF2BP2 HIVEP1 COBLL1 TNRC6B R3HDM2 ACVRL1 WNK1 ZBTB37 TRIM33 MAP4K5 FAM222B AFF1 SSH2 MUC4

9.51e-0488017814EFO_0007978
DiseaseTNF-related apoptosis-inducing ligand measurement

CFH KIF26B TSC22D2 NDUFAF4

9.57e-04721784EFO_0008300
Diseasemannose measurement

SLC5A9 MAP4K5

9.89e-0481782EFO_0006958
Diseaseeosinophil cationic protein measurement

CFH SPATA31C1

9.89e-0481782EFO_0010913
Diseasecytoskeleton-associated protein 2 measurement

CFH APOL1

9.89e-0481782EFO_0020309
DiseasePartial chromosome Y deletion

DAZ4 DAZ1

9.89e-0481782C1507149
Diseasealpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement

CFH C3

9.89e-0481782EFO_0801373
Diseasecentral serous retinopathy

CFH WNK1

9.89e-0481782EFO_0009784
Diseasetyrosine-protein kinase receptor TYRO3 measurement

CFH MGA

9.89e-0481782EFO_0020829
Diseasesialic acid-binding Ig-like lectin 6 measurement

CFH SIGLEC6

9.89e-0481782EFO_0008285
DiseaseMale sterility due to Y-chromosome deletions

DAZ4 DAZ1

9.89e-0481782C2931163
Diseaseopioid-binding protein/cell adhesion molecule measurement

CFH MAP4K5

9.89e-0481782EFO_0020618
Diseasecalcium/calmodulin-dependent protein kinase type 1D measurement

CFH C3

9.89e-0481782EFO_0008063
Diseaseatypical hemolytic-uremic syndrome (is_implicated_in)

CFH C3

9.89e-0481782DOID:0080301 (is_implicated_in)
Diseasetriglycerides:total lipids ratio, intermediate density lipoprotein measurement

COBLL1 MINK1 R3HDM2 MAP4K5 AFF1

1.06e-031271785EFO_0008595, EFO_0020947
Diseasecreatinine measurement

CFH GTPBP4 KIF26B TNRC6B R3HDM2 KIAA1614 DLC1 MAP4K5 PRRC2C NFKB1 SETBP1 CSPG4 KCNMA1 NFAT5 CCDC158

1.08e-0399517815EFO_0004518
DiseaseAutistic Disorder

MARK1 TAF1C KMT2E NLGN4X KCNMA1 PAX6 TNFRSF1B

1.08e-032611787C0004352
DiseaseRenal Cell Carcinoma

CRADD KCNMA1 NAV3 FMN2 MUC4

1.10e-031281785C0007134
DiseaseSarcomatoid Renal Cell Carcinoma

CRADD KCNMA1 NAV3 FMN2 MUC4

1.10e-031281785C1266043
DiseaseChromophobe Renal Cell Carcinoma

CRADD KCNMA1 NAV3 FMN2 MUC4

1.10e-031281785C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

CRADD KCNMA1 NAV3 FMN2 MUC4

1.10e-031281785C1266044
DiseasePapillary Renal Cell Carcinoma

CRADD KCNMA1 NAV3 FMN2 MUC4

1.10e-031281785C1306837
Diseasecoronary aneurysm

ZNF618 COL24A1 SETBP1

1.23e-03351783EFO_1000881
Diseaseretinal vasculature measurement

CFH NFIL3 KCNMA1 NAV3 CAPN5 CTNNB1 R3HDM1 PATJ TNS1 KNL1

1.24e-0351717810EFO_0010554
DiseaseDCN1-like protein 5 measurement

CFH MAP4K5

1.27e-0391782EFO_0801520
DiseaseAtypical hemolytic-uremic syndrome

CFH C3

1.27e-0391782cv:C2931788
Diseasecellular retinoic acid-binding protein 1 measurement

CFH C3

1.27e-0391782EFO_0801463
Diseasetumor necrosis factor ligand superfamily member 14 measurement

CFH C3

1.27e-0391782EFO_0010613
DiseaseC3 glomerulopathy

CFH C3

1.27e-0391782C4087273
DiseaseHemolytic-uremic syndrome

CFH C3

1.27e-0391782cv:C0019061
Diseaseleukocyte immunoglobulin-like receptor subfamily A member 5 measurement

CFH MAP4K5

1.27e-0391782EFO_0801766
DiseaseRNA-binding protein 24 measurement

CFH C3

1.27e-0391782EFO_0802030
DiseaseMalignant neoplasm of prostate

KAT6A AURKA KMT2D HSD3B2 PAX6 CTNNB1 PATJ ZNF160 MGA MUC4 PML

1.36e-0361617811C0376358
DiseaseProstatic Neoplasms

KAT6A AURKA KMT2D HSD3B2 PAX6 CTNNB1 PATJ ZNF160 MGA MUC4 PML

1.36e-0361617811C0033578
Diseaselow density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio

COBLL1 R3HDM2 TSC22D2 MAP4K5 AFF1 NFAT5

1.39e-032001786EFO_0004611, EFO_0020945
Diseasetriglyceride measurement, high density lipoprotein cholesterol measurement

COBLL1 R3HDM2 TSC22D2 BPTF SBNO1 MAP4K5 AFF1

1.43e-032741787EFO_0004530, EFO_0004612
Diseasecholesteryl esters to total lipids in medium LDL percentage

COBLL1 MAP4K5 AFF1

1.44e-03371783EFO_0022252
Diseasecholesterol:total lipids ratio, high density lipoprotein cholesterol measurement

COBLL1 HLX R3HDM2 TSC22D2 BPTF MAP4K5 AFF1

1.49e-032761787EFO_0004612, EFO_0020943
DiseaseDNA-directed RNA polymerases I and III subunit RPAC1 measurement

CFH C3

1.58e-03101782EFO_0801535
DiseaseAtypical Hemolytic Uremic Syndrome

CFH C3

1.58e-03101782C2931788
Diseaseaxin-2 measurement

CFH ITIH1

1.58e-03101782EFO_0801400
DiseaseOCIA domain-containing protein 1 measurement

CFH C3

1.58e-03101782EFO_0008252
DiseaseUterine leiomyoma, estrogen-receptor negative breast cancer

EXPH5 TNRC6B

1.58e-03101782EFO_1000650, HP_0000131

Protein segments in the cluster

PeptideGeneStartEntry
AAQRDTTLIRHSPQP

AMOTL2

591

Q9Y2J4
HSPFRTLNINGQIPT

EPB41

711

P11171
QPPFNRHTVTLSNSV

HSD3B2

311

P26439
TASRQAPPHIELSNS

AKAP2

106

Q9Y2D5
QKQLQATSVPHPVSR

AURKA

76

O14965
LLHSQGPQTPNIRVS

BICD1

836

Q96G01
SNLLASVPSPQRSEH

CSPG4

1731

Q6UVK1
SVLPRTDSHPQLQNS

ALX3

231

O95076
QHLSRLPTIDPNTRT

GTPBP4

156

Q9BZE4
SSSVPHPFQVTLLRN

ARHGEF16

576

Q5VV41
SINPPTLTAHQSNRV

CNOT9

76

Q92600
RHQQTVTIPPKSSLS

C3

881

P01024
NHNVSLVLEATQPPS

ACVRL1

96

P37023
RLVQHPDLASQASPS

ANKRD35

251

Q8N283
NSRQPSNLPGTVAVH

CAPN5

616

O15484
SQPPQIEHGTINSSR

CFH

871

P08603
LVPAPSRTQSAHQSR

FAM186B

576

Q8IYM0
PHVNISATLSPQVIN

DEPDC7

186

Q96QD5
SNELHNPLQTVTRPT

C7orf31

26

Q8N865
RNSAQAPPDSISLHQ

DMRTC1;

136

Q5HYR2
HTSLQIPSQGQPQSQ

BPTF

2506

Q12830
NLRTEHQVPSSVSSP

COBLL1

801

Q53SF7
SGSSSPITIQQHPRL

FAM193A

266

P78312
PQHSSSQPEVNRSLL

C1orf87

291

Q8N0U7
TSQNTQLVRPPIRSH

CKAP2

246

Q8WWK9
SVDNIVQHSPQLSSP

R3HDM1

871

Q15032
ALFQTPLISQHPQQT

R3HDM2

461

Q9Y2K5
TRTVPQSQTQPLHKV

RBM33

916

Q96EV2
SAQLSPQLTVHQPTE

QRICH1

116

Q2TAL8
QPSSVPASQSQVHLR

QRICH2

206

Q9H0J4
QLAAPLTNASSQRHP

IQCN

661

Q9H0B3
LTNASSQRHPPCLSQ

IQCN

666

Q9H0B3
EPQAVQSLRRSSPHT

MSL3P1

266

P0C860
SQANGHQPLRSLPSV

HECW2

781

Q9P2P5
RQASNTPSHIPISSS

PAX6

276

P26367
SQPSVPQAGSNTHRR

CACNA1F

1706

O60840
HSEQRTSPSLSPQVN

MUC16

96

Q8WXI7
SPAVSQRGHTQAPQT

MUC4

631

Q99102
AAHPTNVQRLAEPSQ

CTNNB1

116

P35222
PSLVQDQSSNQTIPH

LINS1

561

Q8NG48
DQSSNQTIPHRLTAP

LINS1

566

Q8NG48
ILSPLNSNPRNSVQH

HLX

236

Q14774
VHSIPSTANRQNRPK

KCNMA1

1206

Q12791
VNTERSHLVPQTPQK

LRRTM4

366

Q86VH4
SPTLRPVSNTQLQGH

MGA

1771

Q8IWI9
HVLFRPTVSQQQSCP

ITIH1

231

P19827
NTTQHPNVTTLAPIS

CD164

26

Q04900
LQPLPTQVVSRGSHN

ELF4

576

Q99607
QDQAATTTVSTPPHR

GPR137

346

Q96N19
QHSASPLVQSPSLQS

KIF26B

1031

Q2KJY2
SQSRAPSLQSLHPVS

KIAA1614

1041

Q5VZ46
AAQRAHTLLSPPSAN

POLD2

6

P49005
LQPIHIQQPATASAT

GPATCH8

1356

Q9UKJ3
LVHATLSTPNPDNQV

ISM2

196

Q6H9L7
LPQQIHSQVTPLSSQ

LTBP1

281

Q14766
QRVTHASPPSEASQA

NAV3

201

Q8IVL0
SHSPPLLQVNRSSSN

NFIL3

256

Q16649
PSTLAHPQAQALARQ

FAM222B

141

Q8WU58
TRSTQAPLPEISNAH

MRTFB

881

Q9ULH7
PTTLPTSQNSIHPVR

PHF21A

271

Q96BD5
RSALQSHQPVARPVS

PHRF1

466

Q9P1Y6
PTVLNSHISTPNVNA

KCT2

56

Q8NC54
PPQTHVRNSSEQLSQ

KMT2E

1416

Q8IZD2
VDLVSRNNQSPSHSP

MYLIP

336

Q8WY64
TVLPNREPSTHVSNQ

EXPH5

1676

Q8NEV8
PHVSKERIQQSLSNP

KNL1

566

Q8NG31
ASHIQPGTVNRVSSP

GATAD2B

321

Q8WXI9
HTLRQAPQPQSSLQR

GATAD2B

506

Q8WXI9
RPPAHISSVRQASTQ

PABPC1L

456

Q4VXU2
QASTQVPRTVPHTQR

PABPC1L

466

Q4VXU2
AQTLNPNALIHPVST

GAL3ST4

251

Q96RP7
SNTVQQHPSTPKRHT

NFAT5

126

O94916
AVQVIQQALHRPPSS

PHC3

46

Q8NDX5
SQRHSQPTVLNLTSP

PKD1L2

1166

Q7Z442
SPISSVQSHPSQSVR

KAT6A

1481

Q92794
VQSHPSQSVRSVSSP

KAT6A

1486

Q92794
PSPQRNTTNDITHIQ

NLGN4Y

711

Q8NFZ3
LSHNSLRATVNPSAP

CD14

256

P08571
HRSPSPNIRNSLENV

BCLAF3

76

A2AJT9
PTQPSAQARCTQHTS

CCDC200

116

A0A1B0GVQ3
ITPNPVTQHVQSAAN

DAZ1

156

Q9NQZ3
ITPNPVTQHVQSAAN

DAZ1

321

Q9NQZ3
SRRSPVSPQLQQQHQ

CPEB2

86

Q7Z5Q1
HTPPGTQTNTAALLN

LINC01599

301

Q8WXQ3
LPQRAAQTTPASHLN

CPLANE1

2271

Q9H799
SHPESVSQSLTPQQQ

FOXJ3

256

Q9UPW0
VLSSSLNNHPQTSVP

CRTC3

341

Q6UUV7
QTSVPNASALHPSLR

CRTC3

351

Q6UUV7
QIPSHSSSIRTVQGP

COL14A1

1641

Q05707
PATVVNDHVPSSSRQ

FNDC1

886

Q4ZHG4
HPNSSQVLQSITEPS

CMYA5

1796

Q8N3K9
TLRQQPPVSTGSATH

HAP1

456

P54257
IPSHILNSSPSDRQI

CRADD

106

P78560
QGQASVPSSPRLETH

CRYBG2

346

Q8N1P7
RTLLPRPSENQSHNV

CRAMP1

891

Q96RY5
LQNQKSSAPVHAPRS

CEP350

551

Q5VT06
ANLQSVPHASASRPR

APOL1

291

O14791
SVLEQLHQAVTSPQP

DENND5A

221

Q6IQ26
HVPVAVSSQPQLLQS

ATF7IP

786

Q6VMQ6
PQLVANVTNPNSTEH

KPNB1

131

Q14974
NPVSQRSSLPVHVGQ

LY9

226

Q9HBG7
NHPNLTCTASNPVSR

LY9

421

Q9HBG7
LRNRNLVHPTQLTSP

MARCHF11

351

A6NNE9
EPHIQPTKSSSRQNI

MARK1

26

Q9P0L2
STPEQAAKNRIQHPS

HNRNPL

486

P14866
VHTQVNTNTTLPKSP

ESCO1

266

Q5FWF5
SRQHVSRGTQQPESP

EME2

191

A4GXA9
ITPNPVTQHVQSAAN

DAZ4

156

Q86SG3
SCPQRTLHVPSNTQK

CCDC168

5581

Q8NDH2
PRLLQPASVTRSHSN

CCDC158

861

Q5M9N0
TTTRQLSSPNHSPSQ

FMN2

421

Q9NZ56
PRRISVQLDSHQPTQ

FMN2

791

Q9NZ56
VQLDSHQPTQSISQP

FMN2

796

Q9NZ56
QPPSTTTFVLNQINH

SBNO1

81

A3KN83
QVHSTTRRNSNSPPS

IRF2BP2

446

Q7Z5L9
PSPQRNTTNDIAHIQ

NLGN4X

711

Q8N0W4
ASSTAQPPTQHRLVA

IRF2BP1

456

Q8IU81
VLESRPTENPTAHSN

MAP4K5

821

Q9Y4K4
PQQQSHLVPVSLSNL

MEF2D

401

Q14814
GRLSTVPSTQSQHPR

REM1

31

O75628
VPSTQSQHPRLGQSA

REM1

36

O75628
PRQTLGTPNTVTNLH

MIB2

806

Q96AX9
NVNPTNTRAHSETPE

MINK1

996

Q8N4C8
LLNPHQPIATQSCAT

OR10J3

86

Q5JRS4
AHLQRALQASVSPPS

PHF1

406

O43189
QPHGALTRVSSVSQP

UTY

491

O14607
SAVHNLQPTQPSLIR

MRPL39

281

Q9NYK5
ASTQLPITHTRQVPS

RHNO1

31

Q9BSD3
PHIPSGIINQSRSAS

STRN3

386

Q13033
TTTTTQQHPRQAAPQ

TRIM33

546

Q9UPN9
NQLSIPQSPRHSSAL

STK16

251

O75716
PQSPRHSSALRQLLN

STK16

256

O75716
VKTSRAVHPTQPSSN

THSD7A

1571

Q9UPZ6
RSQQHVNLSPSPATQ

TMEM200A

21

Q86VY9
VPAPLAQSQQLSSHT

TSC22D2

531

O75157
VIVHTNPDPSNTVNR

NHS

426

Q6T4R5
TRSQQHTPVLSSSQP

TAF1C

846

Q15572
PSQTQEHKPSTQNLL

TEX48

31

A0A1B0GUV7
NIFCSNPNHRTPTLT

PML

186

P29590
QTPTQASNSQFIPIH

SMG7

636

Q92540
THKPVQNPLQTTSQS

PRRC2C

1936

Q9Y520
HTTPQAQAQSLSRPA

PRRC2C

2616

Q9Y520
VLHRQQSQPAKESSP

SATB2

581

Q9UPW6
HAQSSPVVIQPSQHS

KIAA1217

886

Q5T5P2
QSSVLTITPRPQDHS

SIGLEC6

196

O43699
RQAIPNVTVPNTTCH

SLC5A9

246

Q2M3M2
SSPLLPRQSHLVQSR

TANC1

66

Q9C0D5
QIVRSNQPSPAVHSS

TANC2

1611

Q9HCD6
PRHPSTNSLLREQIS

NDUFAF4

31

Q9P032
LASQVPQGHLQSTPT

SPATA31C1

901

P0DKV0
VVLHRSSSPNNTNPF

PHAF1

366

Q9BSU1
QSVRAPATASNHPLN

NPAP1

751

Q9NZP6
QSSHRPSLNSVSLQI

DLC1

1006

Q96QB1
PATHTQPGVQLQSNT

SEPTIN6

71

Q14141
AQLSHGSQPSVRTPL

SATB1

286

Q01826
IRLTVHTPKAQSQPQ

SLFNL1

321

Q499Z3
PHSPNQTLISITNDT

BRS3

6

P32247
LSPIHSNQQTLPRTQ

AFF1

211

P51825
VNSLPQSVNVPSQIH

CCDC110

151

Q8TBZ0
PVTSAQAPRHLQSSA

CDCA4

131

Q9BXL8
HSPQSDSLTQLVQQP

CLMN

961

Q96JQ2
TRISSRQHQASQPPL

CILK1

331

Q9UPZ9
PPHASQTQSLTAQQA

CNK3/IPCEF1

631

G9CGD6
QVLDSPHQRSPSLSL

CNKSR1

296

Q969H4
PILNTSLHRVTNEPS

COL24A1

426

Q17RW2
SHLQPTLLQRAKPSN

PHF13

91

Q86YI8
TVNIPIAPIHSSAQA

TULP4

686

Q9NRJ4
SVVNVNPTNIRPHSD

TNIK

1021

Q9UKE5
SVSPLQQIPSSVQTH

ZNF160

216

Q9HCG1
CATLLHRTPPATQTQ

ZNF618

331

Q5T7W0
ESHRVTPNLNRSLSP

ZBTB37

151

Q5TC79
TPNLNRSLSPRHNTP

ZBTB37

156

Q5TC79
SHSEQNATVPAPRVL

SSH2

946

Q76I76
PTNHQRPSTLIQTPT

SPEM3

611

A0A1B0GUW6
VQSLSSTPRVIPNVH

PATJ

1156

Q8NI35
PIHTPQRTVFNSETQ

TOM1

161

O60784
QHARSPPVTQSRSLS

PLEKHG4B

771

Q96PX9
PAPQRVDSIQVHSSQ

SEMA6A

961

Q9H2E6
AVNATRPTLSATPNH

TNS1

381

Q9HBL0
HSPPISSQNVTVLRD

THY1

111

P04216
NSSVPQRSRHPLQDS

USF3

1971

Q68DE3
PLQRSQSLPHSATVT

TBC1D22A

161

Q8WUA7
LPGDSSSQQHQRPVL

SNX22

126

Q96L94
VSNTHPSRRSQDPAL

ZNF469

1856

Q96JG9
QNTSSPSARCQPHTR

LTBR

176

P36941
SLQRVVLTHPNTPSQ

ZNF454

136

Q8N9F8
NQVVSHPNQPLTITA

STRN4

641

Q9NRL3
LPQPVSTRSQHTQPT

TNFRSF1B

216

P20333
SLTGVSSSQPIQHPQ

WNK1

726

Q9H4A3
QTHTTLSSQALQPRP

ZC3H10

311

Q96K80
PVSVHLQPSLSRQSS

SEMA6D

1016

Q8NFY4
QGAHAQPTLQTPSIQ

TRIM66

421

O15016
SNPENDSSHVRITIP

SETBP1

391

Q9Y6X0
PSPRPQSRAHAQTTN

nan

71

Q6ZTI0
NSHPVPRSNLSIVSI

ZFC3H1

661

O60293
NQIHAPPSHQSTQLS

HIVEP1

1516

P15822
PPSHQSTQLSLQVST

HIVEP1

1521

P15822
QVVRPQESRSLSPSH

ZC3H13

866

Q5T200
TQLQSEATQHKSPVP

ZKSCAN8

166

Q15776
AQSRGLHTPVQPLNS

TNRC6B

1206

Q9UPQ9
CHRSHPNQPLSQTQS

TTC31

476

Q49AM3
QQHSAVLALSPSQSP

KMT2D

3611

O14686
ILLSETRPQNHTPTA

MXRA5

1471

Q9NR99
AHSLPLSPASTRQQI

NFKB1

901

P19838